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ABSTRACT OF THE DISSERTATION 
The Role of Excited States in Determining β-lactamase Function and Bacterial Fitness  
Catherine R Knoverek 
Doctor of Philosophy in Biology and Biomedical Sciences 
Biochemistry, Biophysics, and Structural Biology 
Washington University in St. Louis, 2021 
Associate Professor Gregory R Bowman, PhD, Chair 
Proteins are macromolecular machines that play a role in nearly every biological process. They 
are dynamic molecules which adopt many different conformations as they fold into their 3D 
structures, interact with their binding partners, and perform their functions. The most probable 
(lowest energy) protein conformation is referred to as the ground state, and this is often assumed 
to be the state determined by experimental methods such as x-ray crystallography. However, 
proteins also adopt higher energy excited states which can have significant probabilities. As 
these excited states are notoriously difficult to find and study, it is unclear if excited states 
contribute to the protein’s function and ultimately to the organism’s survival. To investigate this 
question, I examine the excited states of β-lactamases, enzymes which confer bacteria with 
antibiotic resistance by degrading β-lactam antibiotics such as penicillin. I first consider a subset 
of excited states that contain a cryptic pocket, or a pocket which is absent in the ground state 
conformation. I find that the Ω-loop cryptic pocket seen in TEM β-lactamase plays a role in the 
protein’s ability to hydrolyze different classes of antibiotics and specifically that the population 
of open pocket conformations is predictive of activity against the substrate benzylpenicillin. I 
next consider the subset of excited states along the protein folding pathway. I find that β-
 xvi 
lactamase stability contributes significantly to the ability of bacteria expressing β-lactamase to 
survive in the presence of antibiotic and specifically that including the population of folding 
intermediate conformations improves the predictive power of my model for bacterial fitness. 
These results demonstrate our understanding of how excited states are connected to β-lactamase 
function and survival of bacteria expressing β-lactamases. This work also helps establish the 
utility of cryptic pockets as drug targets and aids in our understanding of how mutations 
(genotype) result in changes in fitness (phenotype).  
 
 1 
Chapter 1: Introduction 
 
1.1 Preface 
This chapter is an adapted and expanded upon version of a review published in Trends in 
Biochemical Sciences written by myself, Gaya Amarasinghe, and Gregory Bowman (Knoverek 
CR, Amarasinghe GK, Bowman GR. Advanced Methods for Accessing Protein Shape-Shifting 
Present New Therapeutic Opportunities. Trends Biochem Sci. 2019;44(4):351-364). As the 




1.2 Proteins are Involved in Nearly All Biological Processes 
As a major biological macromolecule, proteins are extremely important for life. They are the 
molecular machines that catalyze reactions, generate force, and respond to the environment. 
While proteins are essential for all of the diverse biological processes, they are all made up of the 
same roughly 20 amino acids. Proteins have the ability to carry out so many different types of 
specific functions because they make use of both amino acid chemistry and a three-dimensional 
structure. Furthermore, proteins also sample many different structures with different likelihoods, 
adding even more potential for complexity in their behavior. 
 
A strength of biochemistry research is its ability to provide molecular mechanisms for biological 
phenomena, and those mechanisms often involve moving proteins. Thus, understanding the ways 
in which a protein moves and how this relates to the protein’s function is not only a fascinating 
biochemical/biophysical question, but has significant implications for all biological problems. If 
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we can better understand the dynamics of a protein, we can better understand its function, and in 
turn better understand what goes wrong during disease.  
 
 
1.3 Proteins are Dynamic Molecules 
1.3.1 A Brief History of Protein Dynamics 
A protein has the potential to adopt an enormous number of different structures. For example, a 
small protein with 100 amino acid residues has ~200 rotatable bonds along its backbone. 
Assuming that each of these rotatable bonds can adopt one of two dominant rotameric states, 
then such a protein can adopt approximately 1060 different backbone structures, not to mention 
the additional possible structures if one considers the rotatable bonds in sidechains. Only a small 
fraction of these structures is capable of performing a given function. The process by which a 
newly synthesized or unfolded protein transitions to one of these functional structures is called 
protein folding and represents a particularly dramatic example of protein shape-shifting. If a 
protein sampled 1,000 different backbone structures each second, it would take about 1040 times 
the age of the universe to enumerate every possibility. The impossibility of enumerating all 
possible structures is often called Levinthal’s Paradox [1]. The number of potential structures is 
dramatically reduced by the fact that many of the configurations considered above are infeasible 
because no pair of atoms can occupy the same volume in space, called the excluded volume 
principle. However, there is still an enormous number of different structures that do not violate 
the excluded volume principle. 
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Figure 1.1 Simplified energy landscape for TEM β-lactamase. Shown is a simplified energy landscape (gray 
mesh) where the y-axis represents energy, and the x-axis represents conformational space. The lowest energy 
structure (bottom) is the ground state, and this is often assumed to be represented by the crystal structure (PDB: 
1xpb). All other structures are then referred to as excited states. Here, several known excited states for TEM β-
lactamase are shown. There are two structures near the ground state that each contain an open cryptic pocket 
(colored orange and magenta on the structures), a structure representing the folding intermediate, and a structure 
representing an unfolded conformation. 
 
The set of possible structures a protein can adopt is often conceptualized as a vast, multi-
dimensional landscape, called an energy landscape (Figure 1.1). This term derives its name from 
the fact that each structure a protein could adopt has an associated energy that results from the 
interactions between different atoms in the protein and its surroundings. The probability of a 
protein adopting a given structure on this energy landscape is proportional to the exponential of 
the structure’s energy. Therefore, a protein spends exponentially more time in valleys than it 
does crossing the higher energy peaks separating different minima. The lowest energy structure 
is often referred to as the ground state and will have the highest probability of all the different 
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structures a protein could adopt. Other higher-energy states are often referred to as excited states 
and will have lower probabilities than the ground state. Many of these excited states have 
negligible probabilities because their energies are so much higher than the ground state. This 
train of thought leaves an open question: how many different structures can a typical protein 
effectively adopt? 
 
Early experiments suggested that a protein can adopt a large number of different conformations. 
For example, the hydrogen exchange technique (also called hydrogen-deuterium exchange, or 
HDX) was originally developed to test the hypothesis that amino acid residues can form helices 
[2]. This method leverages the fact that the bond between the nitrogen and hydrogen in the amide 
of the backbone of every amino acid is relatively weak. Therefore, if a protein is immersed in 
D2O, then the hydrogens of amides that are exposed to solvent will exchange with deuterium. 
However, amides that form hydrogen bonds will be protected from exchange. The complex 
kinetics of early hydrogen exchange experiments suggested a diversity of structures were present 
at equilibrium.  
 
Nuclear magnetic resonance (NMR) has also been a rich source of information on proteins’ 
conformational heterogeneity. NMR provides a means to assess the chemical environment of 
particular nuclei, often the same amide groups monitored by hydrogen exchange experiments. 
NMR, however, can provide information on more than just solvent exposure of the backbone 
amides. For example, early work showed that the phenyl groups of phenylamine residues buried 
in a protein’s core are capable of rotating despite the tight packing of atoms in this environment 
[3]. NMR can also be used for structure determination and to study other conformational 
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changes. However, performing these experiments is often time consuming and expensive. NMR 
also faces a number of technical limitations, such as the difficulty of studying large proteins. 
 
Despite early evidence for dynamics, much of what we know about any given protein often 
comes from a single structure. While NMR can be used for structure determination, the first 
structure of a folded, globular protein was solved by x-ray crystallography [4]. In 
crystallography, protein is prepared under conditions that promote the formation of a regular 
crystal lattice. X-ray beams are then directed at the crystal, and the resulting diffraction pattern is 
used to infer the protein’s structure. Typically, practitioners focus on solving a single structure 
that best explains the diffraction data. Crystallography yields atomic resolution structures with a 
greater throughput than NMR, so it has come to dominate structural biology. Tens of thousands 
of different structures have been deposited into an online repository, called the protein data bank 
(PDB). These structures are often thought to represent the ground state structure in solution, but 
it is more accurate to think of them as the average of many low energy structures under the 
conditions used for crystallization. It is typically hard to capture important excited states without 
stabilizing the higher energy state, such as having a binding partner (i.e., small molecule or 
another protein). Despite this limitation, crystal structures have proved extremely valuable for 
gaining insight into how proteins function, as well as designing drugs and new proteins. The 
wealth of information a crystal structure provides sometimes even leads people to conclude that 
it encodes all the information one could need, rendering the role for protein dynamics negligible. 
For example, many methods for predicting protein stability assume that a single crystal structure 
is sufficient to predict the relative populations of the folded and unfolded states. Computational 
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drug design software also tends to make the simplifying assumption that a single protein 
structure is a sufficient characterization of the protein. 
 
 
1.3.2 Considering Protein Excited States is Important for Understanding 
Protein Function and Ultimately Developing Therapeutics 
Structures from techniques like crystallography and NMR are tremendously valuable, but their 
explanatory and predictive power is limited. The first crystal structure ever solved is a powerful 
illustration [4]. In this structure of myoglobin, the heme group used to bind and hold the 
protein’s substrate, oxygen, is buried within the protein’s core. Oxygen clearly has to get into the 
protein’s core to interact with heme, but it’s not obvious how it does so from this structure. 
Therefore, this first structure was both a demonstration of structural biology’s power and the 
unmet need to capture protein dynamics to achieve a complete understanding of how a protein 
functions. Given a single structure, it is also extremely challenging to predict essential properties 
for understanding a protein’s function, such as its stability [5], its affinity for different binding 
partners [6], or the effect of mutations on its function [7]. Often times, the crystal structures of 
protein variants with dramatically different activities or stabilities are essentially identical, 
making it difficult to explain how mutations exert their effect [8]. It is possible that this lack of 
explanatory and predictive power results from an inability to extract information appropriately 
from available structural data. However, there is mounting evidence that protein dynamics, and 
the conformational diversity these fluctuations give rise to, is a crucial missing factor.  
If we divide the different structures a protein adopts into two classes, functional and non-
functional, we can see that modulating the relative probabilities of these two classes opens a 
number of new therapeutic opportunities. However, this binary classification may not be 
adequate for many proteins, such as those with multiple functions.  
 7 
 
Proteins that must maintain a delicate balance between populating multiple functional structures 
may be particularly attractive therapeutic targets because having more constraints makes them 
more sensitive to perturbations. For example, conformational switches involved in signaling are 
likely to populate at least two distinct functional states—on and off—with reasonably low 
energies, as well as non-functional states with higher energies. Stabilizing or destabilizing any of 
these states may disrupt such proteins’ ability to function appropriately. Furthermore, having 
more constraints to satisfy may make evolving resistance to therapeutics more challenging. 
 
The nucleoprotein from negative sense RNA viruses presents a concrete example. For instance, 
Ebola virus nucleoprotein, like other negative sense RNA viral nucleoproteins, is responsible for 
coating the viral genome to protect it from being recognized and destroyed by a host cell. But 
nucleoprotein must also release RNA to allow the transcription machinery to access the viral 
genome. Recent work suggests that nucleoprotein can accomplish these tasks by switching 
between different conformations to control its affinity for RNA, and that isolated nucleoprotein 
has a reasonable probability of adopting both of these alternative structures in solution [9]. This 
balance enables nucleoprotein to serve as a context-dependent regulatory module, binding tightly 
to RNA until interactions with the transcription complex trigger a conformational change that 
favors dissociation from RNA. Furthermore, a peptide has been isolated from the transcription 
machinery that prevents viral replication by potently inhibiting the interaction between 
nucleoprotein and RNA [10]. It has been proposed that this peptide works by stabilizing 
nucleoprotein conformations that have a lower affinity for RNA [9]. Together, these results 
suggest that the relative populations of these alternative structures are constrained by the need to 
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switch between RNA-bound and RNA-free states and that modulating this equilibrium is a 
powerful therapeutic strategy. I expect many other proteins have similarly constrained equilibria 
and, therefore, can be targeted in a similar fashion. 
 
 
1.4 Capturing Protein Dynamics is Notoriously Difficult  
There is increasing consensus that trying to understand proteins without accounting for their 
shape-shifting is like trying to infer the rules of football from a single photo taken during a game. 
However, it has proven easier to acknowledge the importance of protein dynamics than to 
account for the role it plays in protein function. A growing community has been working to 
remedy this situation by developing methods to access proteins’ excited states. 
 
 
1.4.1 Current Methods for Studying Protein Dynamics 
Solution NMR has been particularly valuable, providing insight into both thermodynamics and 
kinetics. For example, relaxation dispersion NMR spectroscopy can detect the presence of an 
excited state with a population less than 1%. Application of this methodology to an enzyme 
arrested in one step of its catalytic cycle has demonstrated that the next step of the cycle is 
present as an excited state [11]. Such experiments have also revealed a correlation between the 
effects of mutations on dynamics and catalysis [11, 12]. For example, a combination of NMR, 
crystallography, and computer simulations have been used to map out the energy landscapes of 
kinases. Based on these models, it has been possible to rationalize autophosphorylation and the 
effects of cofactors and mutations on these enzymes’ activities [13, 14]. Initially, it was often 
unclear what the excited states uncovered by such experiments looked like. However, it is now 
possible to solve the structures of excited states [15]. Looking beyond solving the structures of 
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particular excited states, NMR is also being used to measure a protein’s conformational entropy 
as a means to quantify the number of accessible excited states [16].   
 
Many other experimental techniques have also provided valuable insight into protein dynamics. 
To give a couple of examples, developments in room-temperature crystallography [17] and cryo-
electron microscopy (CryoEM) [18] are providing new opportunities for obtaining high-
resolution structures of excited states. Typically, crystal structures are solved based on the 
diffraction from a crystal at cryogenic temperatures that favor low energy structures more 
heavily than the temperatures where most proteins operate in vivo. Room-temperature 
crystallography and CryoEM both attempt to capture the distribution of structures that exists at 
more physiologically-relevant temperatures. Multiple structures are often required to fit the 
electron density detected by these methods. The relative contributions of these structures to the 
total density may report on their relative populations in solution. Leveraging this insight into the 
structures of excited states and their populations has led to improved methods for drug design 
[19]. 
 
Molecular dynamics simulations provide a foundation for building atomically-detailed, 
quantitatively predictive models of proteins’ shape-shifting that complement experiments. Such 
simulations are often referred to as computational microscopes because they provide a means to 
watch how the position of every atom in a protein evolves over time [20, 21]. The perfect 
simulation would provide a complete description of a protein’s thermodynamics and kinetics. 
However, these simulations face three key limitations: 1) the accuracy of the force fields used to 
model interatomic interactions, 2) the computational challenge of gathering enough data to 
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sample slow processes, and 3) the scientific challenge of extracting useful information from large 
datasets embedded in high-dimensional spaces. Significant effort has been dedicated to all of 
these issues and is reviewed elsewhere [22, 23].  
 
Work from our lab, among others, has established quantitative agreement between simulations 
and a variety of experiments [24, 25]. These results demonstrate that existing force fields are 
accurate enough for many applications, given that sufficiently large datasets are collected. For 
example, we have shown that the agreement between different ten nanosecond simulations and 
NMR experiments is highly variable, but that ten microsecond simulations reliably yield 
quantitative agreement with these experiments [26]. In agreement with NMR and room-
temperature crystallography, simulations also reveal substantial dynamics in proteins’ cores 
despite the tight packing that one could imagine would prevent conformational changes [27]. 
Due to their agreement with experiments combined with their ability to provide atomistic detail, 
simulations are a powerful means to explain the physical origins of experimental observations, as 
well as to guide the design of new experiments. 
 
 
1.4.2 Remaining Questions About Protein Excited States 
Even once a protein excited state has been successfully identified, it can often be difficult to 
determine how important that state is for the protein’s function. It is still unclear how many 
structures a protein typically adopts with an appreciable population and unclear how much of a 
protein’s energy landscape we need to know in order to have an accurate picture of the protein’s 
function. Because proteins are constantly evolving, it is difficult to determine which protein 
motions are important and which are coincidental. Furthermore, proteins interact with other 
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molecules, and binding events can drastically alter the protein’s energy landscape [11]. However, 
we currently know very little about how a protein’s energy landscape changes as it performs its 
function. 
 
Critically, it is unclear if excited states generally contribute to or detract from a protein’s 
function. Is the ground state conformation the functional conformation and excited states provide 
something like stability or evolvability? Related is our poor understanding of how a protein’s 
dynamics are conserved or evolved over time. Either way, understanding the functional 
importance of excited state conformations would allow us to better identify proteins states that 
are useful as drug targets. 
 
Complexity in protein biochemistry is typically added by considering multiple protein 
conformations or considering the protein’s biological context. However, it is still unclear how 
much of a protein’s in vitro behavior is useful for understanding its in vivo behavior [28]. For 
example, a protein may sample a given set of conformations as it folds in a test tube, but how 
many of those conformations are significantly populated in the cell? Cells contain a whole host 
of protein quality control machinery (e.g., chaperones, proteases, etc.) and little is known about 
how excited states interact with this machinery. 
 
These are not all of the unanswered questions related to protein dynamics. Protein energy 
landscapes are a relatively new concept (first studied as the protein folding problem about 60 
years ago) [29], and there is still much to learn on the subject. We have just started to ask 
detailed questions about specific proteins of interest but are not yet ready to establish wide-
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spread phenomena and guiding principles. That being said, this is an exciting time, as we know 
enough about protein dynamics to have some intuition and understanding and have been quickly 
developing new methodologies to study protein excited states. This allows us to begin to tackle 
some of these important questions. 
 
 
1.5 Excited States Containing Cryptic Pockets Have 
Potential Utility as Drug Targets 
The crystal structures of some proteins clearly present multiple pockets where small molecules 
could potentially bind and influence protein function. However, this is not always the case, and 
some proteins do not have any obvious druggable pockets. Fortunately, proteins’ shape-shifting 
can also populate excited states with pockets that are absent in available crystal structures, called 
cryptic pockets (Figure 1.2). These sites are called cryptic allosteric sites when they coincide 
with allosteric networks. Cryptic allosteric sites with coupling to key functional sites have great 
potential value [30]. Small molecules that bind such sites can exert allosteric control over 
functional sites by modulating the relative probabilities of different protein structures. They can 
either enhance or inhibit activity, depending on whether they increase or decrease the probability 
of functional conformations, respectively [31, 32].  
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Figure 1.2 Known cryptic pockets in TEM β-lactamase. (Left) The structure of the open helix 11/12 pocket (blue, 
PDB: 1pzo) is overlaid on the ligand-free crystal structure (gray, PDB: 1xpb). The region of the pocket is 
highlighted in orange. (Right) The structure of the open Ω-loop pocket (blue, from simulations) is overlaid on the 
ligand-free crystal structure (gray, PDB: 1xpb). The region of the pocket is highlighted in magenta. 
 
Cryptic pockets can also have therapeutic value apart from allostery. For example, a cryptic 
pocket that forms in the middle of a key protein-protein interaction surface could be targeted to 
sterically block that protein-protein interaction. Cryptic pockets that extend known functional 
sites also provide opportunities for developing novel competitive inhibitors. For example, one 
could take an enzyme inhibitor that is known to bind the active site and add additional functional 
groups to leverage a cryptic extension to the active site.  
 
The value of cryptic sites has not been fully realized because it is difficult to identify and target 
them. Most examples of cryptic pockets have been discovered serendipitously through screens 
that are agnostic to whether a hit binds a known functional site or a cryptic pocket. For example, 
a small molecule that binds in a cryptic pocket between the orange helices in Figure 1.2 was 
discovered through a screening campaign [33]. In this particular study, the authors sought to 
identify novel active site inhibitors by computationally docking a large library of chemical 
compounds against TEM β-lactamase’s active site and then experimentally testing the chemicals 
with the highest docking scores. Experimental tests of some of the top ranked compounds 
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confirmed that they inhibited the enzyme. However, solving the co-crystal structures of these 
compounds with the enzyme revealed that they did not function as intended. Instead of binding 
the active site, they turned out to bind a cryptic pocket. 
 
A screening method called tethering has been developed to target a specific site on a protein, 
such as a cryptic site [34]. To achieve this specificity, the method requires the protein to contain 
a single cysteine residue near the site of interest. Satisfying this requirement often requires one or 
more mutations to the protein sequence.  The protein is incubated with a library of chemical 
fragments that are capable of forming a disulfide bond with the cysteine. This disulfide tether 
localizes the compounds to the site of interest. Importantly, a reducing agent is also introduced 
along with the fragment library. This reducing agent ensures that fragments bind reversibly. 
Fragments that have strong non-covalent interactions with the target site will tend to stay bound 
even when the disulfide tether is broken by the reducing agent, while compounds that only form 
weak interactions with the protein will tend to dissociate. As a result, one can identify tight 
binding fragments by mass spectrometry. Tethering has successfully identified a number of 
novel compounds and pockets [35, 36]. However, a cryptic pocket could go unnoticed if the 
fragment library does not happen to contain any sufficiently tight binders. Moreover, it is 
expensive to apply tethering to multiple locations on a protein in search of a cryptic pocket. A 
general method for identifying cryptic sites without requiring the simultaneous discovery of 
compounds that bind them would be valuable for guiding the application of tethering. 
 
Computer simulations provide an alternative approach to discover cryptic sites [37]. One of the 
earliest examples is the discovery of a cryptic binding trench in HIV integrase [38]. Efforts to 
 15 
target this pocket eventually led to the development of raltegravir, a first-line treatment for HIV 
[39]. However, this success has not been replicated in a wide variety of other systems because of 
the challenges that molecular dynamics simulations face, as described above. A variety of 
techniques have been developed to overcome these limitations. Many of these methods use 
enhanced sampling algorithms to improve the performance of molecular dynamics simulations 
[40, 41]. Other approaches attempt to infer cryptic pockets from available crystal structures [42] 
or use alternate simulation strategies, such as the Rosetta software, to identify excited states with 
cryptic pockets [43].  
 
Our lab is actively developing a pipeline that combines simulations and experiments to identify 
and target cryptic pockets, with an emphasis on separating the discovery of cryptic pockets from 
the identification of ligands that bind them. As a first step, we demonstrated that building a 
Markov state model (MSM) for TEM β-lactamase and applying a simple pocket detection 
algorithm to a representative structure for each state in the model readily identified the known 
cryptic pocket between the orange helices in Figure 1.2 [44]. The MSM also captured 
correlations between the structure of the cryptic pocket and that of the active site, consistent with 
the allosteric coupling between these sites. Moreover, the model predicted a multitude of new 
pockets with allosteric coupling to the active site. While many of these pockets are probably poor 
candidates for a drug design campaign [37], we proposed that a subset are potentially viable 
targets. 
 
Thiol labeling experiments are a valuable means to initially test computationally predicted 
cryptic sites [45]. These experiments require a cysteine at a position that is buried in the apo 
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crystal structure but that gets exposed by the opening of a cryptic pocket. Satisfying this 
requirement often requires the introduction of a cysteine. However, in one case, we identified a 
native cysteine that satisfies these criteria, alleviating any concern that introducing a cysteine 
might create a cryptic pocket where none existed before [46]. Then a labeling reagent is 
introduced that is capable of forming a covalent bond with the cysteine if it gets exposed. An 
observed labeling rate that is considerably faster than that expected due to unfolding supports the 
existence of a cryptic pocket. For cryptic allosteric sites, one can also measure the activity of 
labeled protein as a first test for allosteric communication. However, the effect of labeling on 
activity does not necessarily determine the extent or direction of allosteric modulation that other 
compounds may achieve given that compounds that bind the same site can be activating, 
inhibiting, or have no effect on activity [31, 32]. 
 
These findings have inspired new methods to expedite the hunt for cryptic sites. For example, 
our lab has developed a goal-oriented adaptive sampling method, called fluctuation amplification 
of specific traits (FAST) [47], to identify excited states with specific geometric features more 
efficiently. While FAST is entirely general, one of the applications that motivated the 
development of the method was finding cryptic sites by searching for excited states with large 
pocket volumes. While our original work on cryptic pockets in TEM β-lactamase used 100 
microseconds of simulation, FAST reproduces these results with just a few microseconds of 
simulation. Our lab has also developed a new algorithm for quickly extracting interesting excited 
states, such as those with cryptic pockets and cryptic allosteric sites, from large ensembles of 
structures generated with molecular dynamics simulations [46]. These methods have revealed yet 
more pockets in TEM, as well as other β-lactamases, that may be more attractive drug targets 
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(Figure 1.2). In the future, we expect that incorporating quantitative measures of the druggability 
of cryptic sites will also be useful [37].  
 
Assessing the conservation of cryptic sites may also be valuable. One attractive feature of 
sterically blocking enzyme active sites is that selective pressure to maintain function reduces the 
probability of mutations that are likely to disrupt inhibitor binding. If the residues lining a cryptic 
pocket are not constrained, then it may be easier to evolve resistance to compounds that target 
these sites. However, it is possible that many cryptic pockets are not so susceptible to mutation. 
For example, enzyme activity could be just as sensitive to mutations in cryptic allosteric sites 
with strong coupling to the active site as it is to mutations in the active site itself. Therefore, the 
conservation of residues lining different cryptic sites may also be worth considering when trying 
to prioritize different potential targets.   
 
 
1.6 TEM β-lactamase as a Model System 
TEM β-lactamase is a well-characterized enzyme which confers bacteria with antibiotic 
resistance by hydrolyzing, and inactivating, β-lactam antibiotics. The catalytic mechanism of this 
enzyme has been well-studied, including the elucidation of each individual rate constant [48]. 
TEM first binds substrate to form an enzyme-substrate complex. Then, the substrate is acylated 
and subsequently deacylated. Finally, the product is released. It is known that serine-70 is 
important for substrate binding and acylation, while glutamic acid-166 and a catalytic water are 
important for deacylation. The classical substrate of TEM is penicillins, such as benzylpenicillin, 
and the wild-type protein has a low catalytic efficiency against later generation antibiotics, such 
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as cefotaxime. However, TEM can gain increased activity against substrates like cefotaxime with 
only a few mutations. 
 
Interestingly, TEM has two known cryptic pockets (Figure 1.2). As discussed above, the first 
pocket is located between helices 11 and 12 and was discovered serendipitously during a drug 
screening campaign targeting the active site [33]. The second pocket was discovered and 
characterized more recently by our laboratory and is located adjacent to the active site [46]. 
NMR [49] and room temperature crystallography [50] experiments suggest that TEM adopts 
multiple conformations, particularly in the region of this second cryptic pocket. Furthermore, 
dynamics in this region have been observed using molecular dynamics simulations and were 
found to be predictive of catalytic activity[7]. It is also possible that even more cryptic pockets 
exist in TEM, as has been predicted by Markov state models[44]. The characterization of TEM’s 
cryptic pockets as well as its catalytic mechanism make it an excellent model system for 
investigating the connection between cryptic pockets and function. 
 
Because TEM has a singular, essential function in the cell and a selection pressure for its 
evolution that can be easily manipulated in the laboratory, TEM has been the focus of several 
studies on molecular evolution [51-53]. Moreover, between one and six mutations can change 
the substrate profile of the enzyme and allow it to hydrolyze new classes of antibiotics. Thus, 
TEM is not only a protein of interest for answering questions involving protein fitness and 
evolution but is also of great biomedical interest because understanding its evolution is important 




1.7 Hypotheses Addressed in this Thesis 
In Chapter 2 of this thesis, I address the hypothesis that protein excited states can be beneficial 
for function. Specifically, I investigate excited states containing a cryptic pocket. I first test the 
conservation of cryptic pocket opening using thiol labeling experiments. I then gain structural 
insight into the pocket open population by combining NMR and molecular dynamics 
simulations. Finally, by designing mutations which alter the relative probabilities of the ground 
and excited states, I test the importance of the excited state for protein function. 
 
In Chapter 3 of this thesis, I hypothesize that considering protein excited state conformations 
informs how the biophysical properties of a protein effect fitness of the organism. I determine 
which protein properties contribute to fitness, knowing that the properties of a protein are 
ultimately determined by its energy landscape. Then, I use measures of protein activity, stability, 
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Chapter 2: Opening of a Cryptic Pocket in  
β-lactamase Increases Penicillinase Activity 
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Understanding the functional role of protein excited states has important implications for protein 
design and drug discovery. However, because these states are difficult to find and study, it is still 
unclear if excited states simply result from thermal fluctuations and generally detract from 
function or if these states can actually enhance protein function. To investigate this question, we 
consider excited states in β-lactamases and particularly a subset of states containing a cryptic 
pocket which forms under the Ω-loop. Given the known importance of the Ω-loop and the 
presence of this pocket in at least two homologs, we hypothesized that these excited states 
enhance enzyme activity. Using thiol labeling assays to probe Ω-loop pocket dynamics and 
kinetic assays to probe activity, we find that while this pocket is not completely conserved across 
β-lactamase homologs, those with the Ω-loop pocket have a higher activity against the substrate 
benzylpenicillin. We also find that this is true for TEM β-lactamase variants with greater open 
Ω-loop pocket populations. We further investigate the open population using a combination of 
NMR CEST experiments and molecular dynamics simulations. To test our understanding of the 
Ω-loop pocket’s functional role, we designed mutations to enhance/suppress pocket opening and 
observed that benzylpenicillin activity is proportional to the probability of pocket opening in our 
designed variants. The work described here suggests that excited states containing cryptic 
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pockets can be advantageous for function and may be favored by natural selection, increasing the 




While it is well-established that proteins are dynamic molecules [1], it is often unclear what these 
dynamics mean for function. An experimentally derived structural snapshot of a protein, such as 
a crystal structure, is frequently assumed to represent the (highest probability, lowest energy) 
ground state. This snapshot is also frequently assumed to be the functional state of the protein. In 
fact, rigidifying the active site, or increasing the probability of the ground state conformation, is 
often used as a design strategy for improving catalytic activity [2, 3]. In opposition to this 
common assumption, there are several compelling examples of functionally relevant excited 
states [4-9]. However, it is still unclear if excited states in general play a role in function.  
Here, we consider an important class of excited states that contain a ‘cryptic’ pocket, or a pocket 
which is absent in the ligand-free, experimentally determined structure(s). These states are of 
particular interest because of the potential utility of cryptic pockets as drug targets [10]. These 
pockets provide a means to drug otherwise ‘undruggable’ proteins and a means to enhance a 
desired protein activity rather than just inhibit an undesired one [11, 12]. One concern, however, 
with the use of cryptic pockets as drug targets is that it is uncertain if there is a selective pressure 
to maintain the existence of a given pocket or if drug binding to that pocket could be trivially 
evolved away. This is at least partially because it is unknown if excited states containing cryptic 




Despite the many examples of systems which are known to contain cryptic pockets [13-15], their 
functional relevance remains unclear, because these pockets are notoriously difficult to find and 
study. Identification of a cryptic pocket often requires simultaneous discovery of a ligand that 
binds to it [16]. Fortunately, recent advances in computational and experimental tools allow us to 
better identify and study these pockets [1, 17]. To increase sampling during molecular dynamics 
simulations, adaptive sampling methods like FAST [18] and replica exchange methods like 
SWISH [19] have been developed. To analyze these datasets, methods such as Markov state 
models (MSMs) [20] and exposons [21] have been developed. These computational tools can 
then be used to inform experimental methods like room temperature crystallography [22], 
Nuclear Magnetic Resonance (NMR) relaxation techniques [23-25], and thiol labeling assays 
[26]. Previous work using these methods has shown that many different kinds of proteins have 
cryptic pockets and that these pockets can be targeted with drugs to allosterically affect 
functional sites [11, 12, 27, 28]. However, it is still unclear if cryptic pockets have implications 
for function in the absence of ligand binding.  
 
To explore the functional relevance of excited states containing cryptic pockets, we consider a 
set of class A β-lactamases. β-lactamases are enzymes that confer bacteria with antibiotic 
resistance by hydrolyzing β-lactam antibiotics, such as benzylpenicillin and cefotaxime. TEM β-
lactamase, in particular, is an established model system for studying cryptic pockets. TEM has 
two known and well-characterized cryptic pockets. The first, which was found serendipitously 
during a drug screening campaign, is between helices 11 and 12 [16]. The second, which was 
more recently identified in our laboratory [21], forms when the Ω-loop undocks from the protein, 
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so we call this pocket the Ω-loop pocket (Figure 2.1). The Ω-loop pocket was discovered in 
molecular dynamics simulations, confirmed using thiol labeling experiments, and subsequently 
shown to exert control over catalysis at the adjacent active site [21]. We know the Ω-loop 
structure is important as it is necessary for the deacylation of β-lactam antibiotics [29], and we 
have previously shown that the total probability of conformations with a closed Ω-loop is 
predictive of cefotaxime activity [30]. 
 
Figure 2.1 The Ω-loop pocket seen in TEM may open in other β-lactamase homologs. The structures of four β-
lactamase homologs (left) overlay well. TEM (PDB: 1xpb) is shown in green, CTX-M-9 (PDB: 1ylj) is shown in 
cyan, MTB (PDB: 2gdn) is shown in orange, and GNCA (PDB: 4b88) is shown in magenta. The open Ω-loop 
pocket structure in TEM (right) was identified in molecular dynamics simulations. 
 
As we have also found that the Ω-loop pocket is present in CTX-M-9 β-lactamase [21], we 
hypothesize that this pocket may play a role in the enzyme’s function. To test this hypothesis, we 
first examine if the Ω-loop pocket is conserved across β-lactamase homologs and if the presence 
of the pocket is correlated with increased activity against classic β-lactam substrates. Here we 
mean conservation of the phenomenon of cryptic pocket opening, rather than conservation of the 
specific amino acid identities in that region of the protein. We then use activity data for TEM 
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variants and combine NMR with molecular dynamics to gain insight into how the open Ω-loop 
pocket affects the hydrolysis reaction for different substrates. Finally, we design mutations to 
modulate the population of the open Ω-loop pocket to explicitly test whether pocket dynamics 
are predictive of enzymatic activity. 
 
 
2.4 Results and Discussion 
2.4.1 β-lactamase Homologs with Ω-Loop Pockets Hydrolyze Benzylpenicillin 
Faster 
As a first step to determining if the Ω-loop cryptic pocket seen in TEM β-lactamase is 
functionally relevant, we examined if this pocket is conserved across a set of β-lactamase 
homologs. Specifically, we examined MTB, the β-lactamase from M. tuberculosis encoded by 
the blaC gene, and GNCA, the predicted sequence for the last common ancestor of various 
Gram-negative bacteria as determined by ancestral sequence reconstruction [31]. Both of these 
proteins have the same topology as TEM (Figure 2.1, left), but only share about 50% sequence 
identity (Figure 2.2). MTB is a modern-day homolog that is evolutionarily distant from and 
exists in a different environment than TEM, while GNCA is a predicted ancestral sequence of 
TEM (Supplemental Figure 3). Investigating these two homologs allows us to test the 
conservation of the Ω-loop pocket in two evolutionary directions. We know that the Ω-loop 
pocket is conserved in at least one homolog, CTX-M-9 [21], and wider conservation would 
suggest there is a selective pressure to maintain the pocket because it is playing a functional role. 
However, even if this pocket is not perfectly conserved, we hypothesize that the presence of the 
pocket may be correlated with enhanced enzyme activity. While closed Ω-loop conformations of 
TEM β-lactamase are predictive of increased cefotaxime activity [30], there are often activity 
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trade-offs in enzymes [31], where increased activity for one substrate results in decreased 
activity for another. So, while a closed pocket may be beneficial for cefotaxime activity, an open 
pocket may be beneficial for a different substrate, such as benzylpenicillin. 
 
Figure 2.2 β-lactamase homologs have the same topology, but only share about 50% sequence identity. The 
sequence alignment for the four homologs discussed in this study is shown here, with conserved residues shown in 
blue. The Ω-loop and 238-loop sequences are underlined. 
 
To determine if the Ω-loop pocket is present in each homolog, we performed thiol labeling 
experiments that monitor the solvent exposure of a cysteine residue due to pocket opening. In 
these experiments, 5,5'-dithiobis-(2-nitrobenzoic acid), or DTNB, is added to the protein sample. 
DTNB covalently modifies exposed cysteine residues in a reaction that can be monitored as a 
change in absorbance at 412 nm over time. If a cysteine is buried inside of a pocket but then is 
exposed to solvent when the pocket opens, we observe an exponential increase in absorbance 
during the time scale of our experiment. We also ensure that the observed labeling rate is faster 
than the expected labeling due to protein unfolding, which is calculated from measuring the 
stability and/or unfolding rate. We have used this method previously to validate known [26], and 
identify new [21], cryptic pockets in TEM β-lactamase. As MTB and GNCA both have multiple 
native cysteine residues, with one cysteine located in the region of the Ω-loop pocket (Figure 
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2.3a-b), we added DTNB to each wild type homolog, monitored the change in absorbance, and 
used Beer’s law to calculate the number of cysteines labeling over time. When cysteine labeling 
was observed, we individually mutated out each native cysteine to determine which one is 
labeling in the wild type protein. For each homolog, we also measured the activity, beginning 
with the classic substrate, benzylpenicillin. 
 
Figure 2.3 Labeling of MTB and GNCA β-lactamases suggest that neither protein open an Ω-loop pocket 
under the conditions tested. A-B. Structures of wild type (WT) MTB (PDB: 2gdn) and wild type GNCA (PDB: 
4b88) are shown with native cysteine residues highlighted in gray. C69 is located in the region of the Ω-loop pocket 
for both proteins. C. The normalized DTNB labeling trace for WT MTB (orange circles) plateaus at one cysteine 
labeling. MTB C287S (light orange pentagons) shows significantly reduced labeling. D. The normalized labeling 
trace for WT GNCA shows no cysteine labeling. 
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For the conditions we tested, we find that neither MTB nor GNCA open a pocket in the region of 
the Ω-loop. Labeling of wild type MTB is well-fit by a single exponential (Figure 2.4), faster 
than expected due to unfolding (Figure 2.5), and plateaus at the expected value for one cysteine 
labeling (Figure 2.3c). However, when we mutate out the cysteine residue in the Ω-loop pocket 
region, C69, the labeling overlays well with the wild type protein (Figure 2.6). MTB C287S, 
however, displays significantly reduced labeling, suggesting that this is the cysteine that labels in 
the wild type protein. Thus, MTB does not open an Ω-loop pocket under the conditions tested 
here. Following the same procedure, we do not observe any significant labeling for wild type 
GNCA (Figure 2.3d). Again, the cysteine residue in the Ω-loop pocket region, C69, does not 
label, suggesting that GNCA also does not open an Ω-loop pocket under these conditions. 
 
Figure 2.4 Labeling of WT MTB is well-fit by a single exponential. Shown here is the average labeling trace for 
30 µM protein and 2 mM DTNB. Raw data is shown as circles and the fit is shown as a solid line. Below are the 




Figure 2.5 Labeling of WT MTB was not due to protein unfolding. (Left) Urea denaturation was followed by 
circular dichroism. Error is reported as the standard deviation of three replicate experiments. (Right) The unfolding 
rate was monitored by circular dichroism and then plotted as a function of urea concentration. The y-intercept of the 
fit line represents the unfolding rate in the absence of urea. 
 
 
Figure 2.6 Mutating out the cysteine residue in the Ω-loop pocket region, C69, does not reduce labeling. The 
normalized DTNB labeling of MTB C69S (coral pentagons) overlays well with the labeling of WT MTB (orange 




Table 2.1 β-lactamase homologs with open Ω-loop pockets display increased catalytic rates against 
benzylpenicillin. 
Protein Ω-Loop Pocket Open Population (%) kcat/KM (sec
-1µM-1) kcat (sec-1) KM (µM-1) 
Penicillin Binding 
Proteins N/A – no Ω-loop 
N/A – cannot 
deacylate penicillin N/A N/A 
GNCA β-lactamase N/A – no Ω-loop pocket 0.40 ± 0.02 6.1 ± 0.1 15.1 ± 0.7 
MTB β-lactamase N/A – no Ω-loop pocket 0.64 ± 0.01 47.0 ± 0.9 72.9 ± 0.8 
CTX-M-9 β-lactamase 0.023 ± 0.008‡ 9 ± 2 250 ± 20 27 ± 4 
TEM β-lactamase† 1.1 ± 0.2‡ 15.2 ± 0.6 411 ± 5 27 ± 1 
† Including an S243C mutation needed for thiol labeling measurements 
‡ Porter et al., 2019 
 
We also find, however, that the β-lactamase homologs with Ω-loop pockets display an increased 
ability to hydrolyze benzylpenicillin (Table 2.1 and Figure 2.7). Penicillin binding proteins, 
which are unable to hydrolyze benzylpenicillin, lack the Ω-loop entirely [29]. The existence of 
this loop, and E166 in particular, in the MTB and GNCA homologs allows for the deacylation 
and completed hydrolysis of benzylpenicillin with moderate catalytic efficiency. However, TEM 
and CTX-M-9 both not only have the Ω-loop but are able to open a pocket in this region of the 
protein and have a corresponding increase in their ability to hydrolyze benzylpenicillin. If the 
substrate binding (~KM) but not the catalytic rate (kcat) was improved, that would suggest the 
pocket opening simply allows for the substrate to more easily enter the active site. However, 
both the overall catalytic efficiency and the catalytic rate are higher for TEM and CTX-M-9 than 
for MTB and GNCA. As a note, we do not expect the change in magnitude of the pocket open 
population to perfectly correspond to the change in catalytic rate. Our thiol labeling experiments 
monitor the equilibrium fluctuations of the apoenzyme while several β-lactamase conformations 
at various ligand binding stages are sampled during our activity assays. Also, because a more 
open pocket is beneficial, the increase in activity is not simply due to an increase in proximity of 
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the catalytic residues. So, while the Ω-loop pocket is not conserved across all β-lactamase 
homologs, the pocket appears to be functionally relevant, because benzylpenicillin hydrolysis is 
increased when the pocket is present. 
 
Figure 2.7 β-lactamases with Ω-loop pockets have higher catalytic rates against benzylpenicillin. The full 
Michaelis-Menten equation was fit to the data. Error bars are shown as the standard deviation of three replicate 





2.4.2 TEM β-lactamase Variants with Higher Probabilities of Ω-Loop Pocket 
Opening Display Corresponding Increases in Benzylpenicillin Activity  
To further test whether the Ω-loop pocket plays a role in the hydrolysis of benzylpenicillin, we 
focus our attention on a set of TEM variants. For TEM variants specifically, we have 
previously shown that there is a strong correlation between cefotaxime activity and the 
population of conformations with closed Ω-loop pockets [30]. So, we focus the rest of our study 
on TEM and hypothesize that an open Ω-loop pocket is detrimental for cefotaxime activity but 
beneficial for benzylpenicillin activity.  
 
To begin investigating this hypothesis, we re-analyzed data from our previous study [30] where 
both benzylpenicillin and cefotaxime activity were measured for a number of TEM variants with 
mutations at clinically relevant positions. In the study, the benzylpenicillin activities were 
reported but not explored for their connection to the Ω-loop pocket dynamics. However, because 
of the correlation found between the Ω-loop closed conformations and cefotaxime activity, 
variants with decreased cefotaxime activity also have a higher population of conformations with 
an open Ω-loop pocket. Here, we examine how the catalytic rate for benzylpenicillin correlates 
to the catalytic efficiency against cefotaxime to determine if there is a trade-off between the two 
substrates, as this would suggest TEM variants with a higher population of open Ω-loop pocket 
conformations also have increased benzylpenicillin activity.  
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Figure 2.8. There is an inverse correlation between benzylpenicillin and cefotaxime activity for TEM variants. 
Each point represents a different TEM variant. Error bars represent standard error values from the fits. The variants 
shown in gray are R164E/G238S and R164D/G238S, which have decreased activity against both substrates. Data 
originally reported in [30]. 
 
In fact, we do find a trade-off between benzylpenicillin and cefotaxime activity in the TEM 
variants examined here. We find that when TEM gains mutations that significantly increase 
cefotaxime activity, this corresponds to a decrease in catalytic rate for benzylpenicillin (Figure 
2.8). As increased cefotaxime activity for these variants is correlated with a lower population of 
Ω-loop open conformations, the opposite is also true. Variants with a higher population of Ω-
loop open conformations are correlated with increased benzylpenicillin activity. The variants 
form two distinct clusters, with the exception of TEM R164E/G238S and R164D/G238S (shown 
in gray), which display low activity against both substrates. Positions 164 and 238 are known to 
exhibit negative epistasis with one another [32], so these variants likely have perturbed Ω-loop 





2.4.3 NMR and Simulations Provide Structural Insight into the TEM Ω-Loop 
Pocket Open Population Without the Need for a Mutation  
To structurally characterize the open Ω-loop pocket population, we used a combination of NMR 
and molecular dynamics simulations. We performed an NMR relaxation technique called 
Chemical Exchange Saturation Transfer (CEST) [33, 34], which allows us to observe motions on 
the same timescale as our labeling experiments but without the need for a cysteine mutation. 
CEST can identify the presence of excited states and the rates of transitioning between states, 
thereby complementing our thiol labeling experiments. These NMR experiments also identify 
which residues contribute to the exchange between the ground state and excited state(s), which 
we used to inform the collective variable for metadynamics simulations. We then used 
conformations found during our metadynamics simulations to act as starting conformations for 
unbiased simulations on the Folding@home distributed computing platform [28, 35]. This 
“adaptive seeding” strategy allows us to access protein motions on the longer timescales of our 
labeling and NMR experiments while still preserving the thermodynamic and kinetic properties 
of the system. To analyze our simulation data, we used Correlation of All Rotameric and 
Dynamical States (CARDS) [36] followed by Principal Component Analysis (PCA) to identify 
the motions associated with the Ω-loop pocket and pull out exemplar structures for the pocket 
open and closed populations (Figure 2.9). 
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Figure 2.9 Simulation data was analyzed using CARDS and PCA. (Left) Each color highlighted on the WT TEM 
structure (pdb: 1xpb) represents a different CARDS community. These communities are residues which have 
correlated dihedral motions. The orange community includes the Ω-loop and the catalytic S70. (Right) We 
performed PCA on the orange community and found two resolved minima. The colored circles represent the 




Figure 2.10 Structural insight into the TEM open Ω-loop pocket population identifies conformational changes 
in the 238-loop and catalytic S70. A. Highlighted in green on the wild type (WT) TEM structure (PDB: 1xpb) are 
the residues showing conformational exchange as established by minor dips in the 15N CEST profiles. Residues 
around the Ω-loop pocket are annotated. B. 15N CEST profiles for wild type TEM (green circles) and TEM R241P, a 
variant with no Ω-loop pocket, (light green pentagons) are shown for residues in the Ω-loop pocket. Minor dips seen 
in the wild-type protein are highlighted with arrows. These experiments informed molecular dynamics simulations 
that identified the structures shown in C. C. The closed pocket conformation (white) is similar to the crystal 
structure. The open pocket conformation (green) has an open Ω-loop, an open 238-loop, and a buried catalytic S70 
(shown in sticks).  
 
Our CEST experiments provide further evidence for the TEM excited states predicted from our 
simulations and corroborate DTNB labeling data without the need for a mutation. Exchange was 
observed for TEM, suggesting the presence of an excited state population (Figure 2.10a). Many 
of the residues around the Ω-loop pocket report on to the exchange between the states, including 
L169, N170, G236, E240, G242, and S243 (Figure 2.10b, circles). The population of the excited 
state was determined to be 1.05 ± 0.03% (kex = 98 ± 6 sec-1), which is in excellent agreement 
with the open pocket population measured using thiol labeling (1.1± 0.2%). Furthermore, when 
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we perform the same experiment on TEM with a mutation that abolishes the Ω-loop pocket 
(R241P, see data below), the dynamics monitored by CEST disappear (Figure 2.10b, pentagons) 
as well as faster timescale dynamics monitored by relaxation dispersion (Figure 2.11). These 
data suggest that CEST reports on the Ω-loop pocket open population. We then used the residues 
identified in these experiments as being dynamic on the millisecond to second timescale to 
define the collective variable for metadynamics simulations, which in turn identified seed 
conformations for unbiased simulations. 
 
Figure 2.11 The R241P mutation in TEM removes dynamics on the microsecond to millisecond timescale as 
monitored by relaxation dispersion. (Left) Highlighted in green on the wild type (WT) TEM structure (PDB: 
1xpb) are the residues showing conformational exchange as established by Car-Purcell-Meiboom-Gill (CPMG) 
experiments. (Right) 15N CPMG profiles for wild type TEM (green circles) and TEM R241P, a variant with no Ω-
loop pocket, (light green pentagons) are shown for a set of representative residues.  
 
Analysis of our simulations show an Ω-loop pocket open state with an open Ω-loop and open 
238-loop (Figure 2.10c), in good agreement with the NMR experiments reported here as well as 
our previous thiol labeling of this pocket [21]. We find that the Ω-loop closed conformation 
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looks very similar to the crystal structure, as expected. We also find that Ω-loop pocket opening 
is correlated with burial of the catalytic serine (S70), making the residue no longer available to 
bind substrate (Figure 2.12). We observed above that closed Ω-loop pocket conformations were 
generally beneficial for substrate binding, which is consistent with the closed conformation 
containing an S70 that is available to bind substrate. These structural results also provide insight 
into why a higher population of open pocket conformations may be beneficial for a larger 
substrate, and vice versa. Wild-type TEM β-lactamase degrades cefotaxime poorly and the 
reaction is rate-limited by the acylation rate [37, 38]. We reasoned that a more closed Ω-loop 
pocket would increase protein-substrate contacts, and an available S70 would be beneficial for 
substrate binding and subsequent acylation. TEM hydrolyzes benzylpenicillin, on the other hand, 
with an efficiency approaching the diffusion limit [39, 40]. In this case, an open Ω-loop pocket 
may promote product release by reducing protein-product contacts while having a minimal 
impact on substrate binding. Specifically, we expect a small decrease in acylation rate due to the 
buried S70 can be tolerated, given the already very fast acylation rate and overall small 
population of the pocket open conformations. 
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Figure 2.12 Ω-loop pocket opening is correlated with S70 burial. A 2D histogram of catalytic S70 burial as a 
function of Ω-loop pocket opening shows that when the pocket is open, S70 is predominantly buried. S70 burial is 
captured using a backbone hydrogen bond distance between S70 and K73. The Ω-loop opening distance is 
characterized by the Cα-Cα distance between E240 and E171. 
 
 
2.4.4 Variants Designed to Modulate the Dynamics of the Ω-Loop Pocket 
Predictably Affect Function 
Finally, we explicitly test our model by designing variants to either close or open the Ω-loop 
pocket, assessing the impact on pocket opening via thiol labeling experiments, and observing the 
effects on both benzylpenicillin and cefotaxime hydrolysis functions. We aimed to make 
mutations in TEM that are not known to be involved in catalysis directly but that would affect 
the Ω-loop pocket dynamics. Thus, changes in the pocket dynamics resulting in predictable 
changes in activity would support our understanding of how the TEM Ω-loop pocket is 
connected to function.  
 
Towards that end, we selected Ω-loop pocket mutations based off of a previous study [41] that 
measured the fitness effects of every single point mutation in TEM in the presence of either 
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ampicillin or cefotaxime. An E240D mutation produced a positive fitness effect in the presence 
of ampicillin. While a mutation to lysine at this position is known to be clinically important, the 
charge conserving mutation to aspartic acid at this position has not been seen clinically. We 
rationalized that mutating this position to an aspartic acid would destabilize closed Ω-loop 
conformations due to its shorter hydrocarbon chain leading to lower hydrophobicity and reduced 
ability to screen its charged, acid group by positioning it into the solvent. Following this logic, 
we hypothesized that the E240D mutation opens the Ω-loop pocket in TEM, which in turn 
increases benzylpenicillin activity. On the other hand, a R241P mutation produced a large 
positive fitness effect in the presence of cefotaxime. This position is not known to be clinically 
important, and we reasoned that removal of a charged amino acid might stabilize closed 
conformations and introduction of a proline, which has fewer available dihedral angles, would 
destabilize open conformations. Thus, we hypothesized that the R241P mutation closes the Ω-




Figure 2.13 Mutations in TEM designed to alter the open Ω-loop pocket population lead to predictable 
changes in benzylpenicillin and cefotaxime activity. A. The observed labeling rate as a function of DTNB 
concentration is shown for wild type (WT) TEM (circles), TEM E240D (triangles), TEM R241P (pentagons), and 
TEM E240D/R241P (diamonds). Higher labeling rates are due to a higher open Ω-loop pocket population. The 
dashed line represents the expected labeling for wild type TEM due to the unfolded population. Error bars represent 
the standard deviation of three measurements. B. Benzylpenicillin (solid) and cefotaxime (striped) activity is shown 




Figure 2.14 The R241P mutation increases cefotaxime activity and decreases benzylpenicillin activity, while 
the E240D mutation decreases cefotaxime activity and increases benzylpenicillin activity. The full Michaelis-
Menten equation was fit to the benzylpenicillin activities. A line with a slope equal to the catalytic efficiency 
multiplied by the enzyme concentration was fit to the cefotaxime activities. Error bars are shown as the standard 
deviation of three replicate measurements. Error for each parameter was determined using bootstrapping. 
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As predicted, we find that the E240D mutation opens the Ω-loop pocket, decreases cefotaxime 
activity, and increases benzylpenicillin activity (Figure 2.13 and Figure 2.14). The thiol labeling 
rates for TEM E240D are faster than wild type, indicating a more open Ω-loop pocket 
(population = 4 ± 1%, EXX regime). As expected, the catalytic efficiency of E240D for 
benzylpenicillin increases. The relatively small increase is also expected as TEM functions very 
close to the diffusion limit for this substrate. We also see the corresponding decrease in 
cefotaxime activity for this mutant.  
Table 2.2 In order to determine existence of the Ω-loop pocket, the pocket population should be higher than 
the unfolded population.  
 
 
We find that the R241P mutation also behaves as expected. The thiol labeling rates for TEM 
R241P are much slower than wild type. In fact, they are on the order of magnitude as those 
expected for labeling due to protein unfolding (Table 2.2 and Figure 2.15), thus suggesting that 
R241P abolishes the Ω-loop pocket in TEM. As a result, the activity of R241P against 
benzylpenicillin decreases, and we find a corresponding increase in the catalytic efficiency 
against cefotaxime, which is consistent with our model and suggests that the mutation does not 
just simply break the enzyme.  
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Figure 2.15 The labeling rates for TEM R241P are on the order of magnitude as those expected for labeling 
due to protein unfolding, while the rates for TEM E240D are much faster. Urea denaturation was followed by 
circular dichroism for TEM R241P (left), TEM E240D/R241P (middle), and TEM E240D (right). Error is reported 
as the standard deviation of three replicate experiments. 
 
When we introduce the E240D mutation into the background of R241P, we find that the opening 
of the Ω-loop pocket is rescued (Figure 2.13a, population = 0.19 ± 0.01%, EX2 regime). The 
corresponding benzylpenicillin activity for TEM E240D/R241P is, as expected, higher than that 
of TEM R241P. It is also lower than that of wild type TEM, consistent with the stronger effect of 
the R241P mutation than that of the E240D mutation in the wild-type background. These data 
support our hypothesis that a higher open Ω-loop pocket population in TEM is correlated with 
higher benzylpenicillin activity. TEM E240D/R241P also has increased cefotaxime activity 
compared to wild type TEM, which is consistent with our model that closed Ω-loop 
conformations are beneficial for cefotaxime activity. However, the cefotaxime activity of TEM 
E240D/R241P, which has a low Ω-loop pocket open population, is greater than the cefotaxime 
activity for TEM R241P, which does not have an Ω-loop pocket. This suggests that, even though 
closed Ω-loop pocket conformations are beneficial for cefotaxime activity, a low open pocket 
population may be more advantageous than no pocket at all, or that specific closed pocket 
conformations additionally tune activity. Taken together, the results presented here suggest that 
 49 
the Ω-loop pocket in β-lactamase plays a role in function, as excited states containing an open 




We hypothesized that β-lactamase excited states play a role in function by increasing enzyme 
activity. Specifically, we investigated whether excited states containing the Ω-loop cryptic 
pocket enhance benzylpenicillin activity. We found that the Ω-loop pocket seen in TEM and 
CTX-M-9 β-lactamase is not conserved in the MTB and GNCA homologs, but that homologs 
with the pocket have higher catalytic rates for the hydrolysis of benzylpenicillin. Focusing our 
study on TEM β-lactamase, we found that variants with larger open Ω-loop pocket populations 
also have higher benzylpenicillin catalytic rates. To gain structural insight into the TEM open Ω-
loop pocket population, we performed NMR CEST experiments and NMR-guided molecular 
dynamics simulations. Lastly, we designed mutations to modulate the dynamics of the Ω-loop 
pocket in TEM and observed that the probability of pocket opening is predictive of 
benzylpenicillin activity. Our results demonstrate our understanding of how excited states 
containing the Ω-loop cryptic pocket are connected to β-lactamase function and provide further 
evidence for the hypothesis that functionally relevant conformations are sampled during 
equilibrium fluctuations (i.e., in the apoenzyme). This work also demonstrates that cryptic pocket 
dynamics can be modulated with mutations, setting up future studies to elucidate the sequence 
determinants of these pockets, and suggests that cryptic pockets may be under positive selective 





2.6.1 Mutagenesis and Protein Purification 
We previously cloned the genes for TEM and CTX-M-9 β-lactamase into pET24-b plasmids 
(Life Technologies) for inducible protein expression under the T7 promoter [21, 30]. Both 
plasmids use kanamycin resistance for selection and the TEM plasmid contains the OmpA signal 
sequence for periplasmic export. MTB and GNCA were cloned into pET28 plasmids by Genewiz 
for inducible protein expression under the T7 promoter. Both plasmids use kanamycin resistance 
for selection. The MTB plasmid contains an N-terminal 6x His tag with thrombin cleavage site, 
and the GNCA plasmid contains the OmpA signal sequence for periplasmic export. We created 
protein variants using site-directed mutagenesis and verified the mutations via DNA sequencing. 
For expression, we transformed our desired plasmid into BL21(DE3) cells (Intact Genomics) and 
grew cultures to an OD600 of 0.6 before we induced protein expression by adding 1 mM IPTG. 
TEM, MTB, and GNCA were expressed overnight at 18°C, while CTX-M-9 was expressed for at 
least three hours at 37°C. 
 
We purified TEM and GNCA using our previously described protocol [30] that isolates the 
protein from the periplasm using the following osmotic shock lysis protocol. We harvested cells 
and resuspended them in 30 mM Tris, pH 8.0 with 20% sucrose. After centrifugation, we 
resuspended the cells in 5 mM MgSO4 at 4°C. After another centrifugation, we dialyzed the 
supernatant against 20 mM sodium acetate, pH 5.5 overnight at 4°C. We centrifuged the dialysis 
contents to remove any insoluble protein and then purified using cation exchange 
chromatography (BioRad UNOsphere Rapid S column) with an NaCl gradient. The final 
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purification step was size exclusion chromatography (BioRad ENrich SEC 70 column), and we 
stored the purified protein at 4°C in 20 mM Tris, pH 8.0. 
 
We purified CTX-M-9 as previously described [21] by isolating the protein from inclusion 
bodies using the following protocol. We harvested cells and resuspended them in 20 mM sodium 
acetate, pH 5.5 and froze them at -80°C at least overnight. We then thawed the cells and lysed 
them via sonication. We centrifuged the lysate, and resuspended the pellet in 20 mM sodium 
acetate, pH 5.5 + 9 M urea overnight. After centrifugation, we refolded the protein by adding it 
drop-wise to buffer with no urea while gently stirring. We removed aggregated protein by 
centrifugation and dialyzed the supernatant against 20 mM sodium acetate, pH 5.5 overnight at 
4°C. After centrifuging the dialysis contents to remove any insoluble protein, we then purified 
using cation exchange chromatography (BioRad UNOsphere Rapid S column) with an NaCl 
gradient. The final purification step was size exclusion chromatography (BioRad ENrich SEC 70 
column), and we stored the purified protein at 4°C in 20 mM Tris, pH 8.0. 
 
We purified MTB by isolating the protein from the cytoplasm using the 6x His tag and the 
following protocol. Cells were harvested and resuspended in 25 mM Tris, pH 7.5 + 300 mM 
NaCl and frozen at -80°C overnight. Cells were then thawed and lysed via sonication. The lysate 
was centrifuged to remove cell debris and the supernatant was loaded onto a Ni-NTA agarose 
column. Elution peak fractions were then dialyzed against 25 mM Tris, pH 7.5 + 300 mM NaCl 
overnight at 4°C. The dialysis contents were centrifuged to remove any insoluble protein before 
the 6x His tag was removed by thrombin cleavage. The reaction was carried out overnight at 
room temperature while stirring. The reaction contents were centrifuged to remove any insoluble 
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protein and then cleaved protein was isolated by collecting the flow-through of a Ni-NTA 
agarose column run. The final purification step was size exclusion chromatography (BioRad 
ENrich SEC 70 column), and the purified protein was stored at 4°C in 20 mM Tris, pH 8.0. 
 
 
2.6.2 Labeling Assays 
For pocket determination, we labeled 5-30 µM protein with 2 mM DTNB (Ellman’s reagent, 
Thermo Scientific) in 20 mM Tris, pH 8.0 at 25°C until completion. We monitored the reaction 
via a change in absorbance at 412 nm over time using a Cary 100 UV–Vis spectrophotometer 
(Agilent Technologies). Each measurement was performed in triplicate. We determined the 
number of cysteines that labeled by first using a series of exponentials fit to the data and then by 
normalizing the signal using the known protein concentration and Beer’s Law (below). Here, 𝑙 is 
the pathlength of the cuvette, which is one cm, and 𝜀 is the extinction coefficient of TNB at 412 
nm, which is 14,150 M-1 cm-1 [42]. 
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 = 𝑙 ∗ 	𝜀	 ∗ [𝑝𝑟𝑜𝑡𝑒𝑖𝑛] (2.1) 
For labeling of the Ω-loop pocket of the TEM variants, we labeled 10 µM protein with various 
concentrations of DTNB (Ellman’s reagent, Thermo Scientific) in 20 mM Tris, pH 8.0 at 25°C 
until completion. We introduced an S243C mutation in order to observe pocket opening via 
labeling, as previous described [21]. We monitored the reaction via a change in absorbance at 
412 nm over time using a Cary 100 UV–Vis spectrophotometer (Agilent Technologies) and 
performed measurements at each DTNB concentration in triplicate. Next, we fit a single 
exponential equation to the data to obtain the observed rate constants and plotted these values as 
a function of DTNB concentration. We fit the Linderstrøm-Lang model [43] (below) to the 
observed rate constants as a function of DTNB concentration to obtain the open pocket 
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population, and obtained error using bootstrapping. We find that the TEM variants reported in 
this study displayed labeling in the EXX (full expression) or EX2 regime. The EX2 regime is the 
limiting case when the rate of pocket closing is much faster than the intrinsic rate of labeling, and 
the observed rate depends linearly on the DTNB concentration.  
𝑘!"# =
𝑘!$ ∗ 𝑘%&' ∗ [𝐷𝑇𝑁𝐵]





∗ 𝑘%&' ∗ [𝐷𝑇𝑁𝐵] = 	𝐾!$ ()⁄ ∗ 𝑘%&' ∗ [𝐷𝑇𝑁𝐵] (2.3) 
Here, 𝑘!"# is the observed labeling rate, 𝑘!$ is the rate of pocket opening, 𝑘() is the rate of 
pocket closing, and 𝑘%&' is the intrinsic labeling rate. We previously measured the intrinsic 
labeling rate (6.83 sec-1 mM-1) by performing the same labeling experiment but on a five amino 
acid peptide of protein sequence containing the cysteine of interest [21]. The equilibrium 
constant for pocket opening (𝐾!$ ()⁄ ) should be greater than the equilibrium constant for 
unfolding, which was measured using urea denaturation experiments (see below). Using linear 
extrapolation, we determined the equilibrium constant for unfolding in the absence of denaturant 
and used the wild-type TEM unfolding equilibrium constant in equation (3) to calculate 𝑘!"# as a 
function of DTNB concentration due to unfolding (dashed line in main text Figure 2.5a). The 
observed rates are expected to be slow because TEM is a stable protein, meaning that the 
concentration of folded protein is greater than the concentration of unfolded protein and the 
equilibrium constant for unfolding is << 1. 
 
 
2.6.3 Urea Denaturation Experiments 
We prepared samples of 35 µg/mL protein in 50 mM potassium phosphate, pH 7.0 at various 
concentrations of urea and equilibrated the samples at room temperature overnight. After one-
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minute incubation in an Applied Photophysics Chirascan equipped with a Quantum Northwest 
Inc. TC125 Peltier-controlled cuvette holder, we monitored circular dichroism (𝐶𝐷) signal at 222 
nm. We recorded the signal for one minute at 25°C in a one cm path length quartz cuvette. Then, 
we measured the refractive indexes of each sample in order to the determine their precise urea 
concentration. We determined the free energy values by fitting a two-state folding model (below) 
to the CD data and using the linear extrapolation method [44]. Each variant was measured in 
triplicate experiments. 
𝐶𝐷 = 	
𝜃/ +	𝜃0 ∗ 𝑒1(3456∗[9:;<]) ?∗@⁄
1 +	𝑒1(3456∗[9:;<]) ?∗@⁄
	 (2.9) 
Here, 𝜃/ and 𝜃0 are the CD signals for the unfolded and folded states, fit as lines.		Δ𝐺 is the 
extrapolated free energy difference between the unfolded and folded states in the absence of 
urea, and 𝑚 is the proportionality constant related to the steepness of the folding transition. 𝑅 is 
the gas constant and 𝑇 is temperature. 
 
 
2.6.4 Urea Unfolding Kinetics 
We prepared a protein sample in 50 mM potassium phosphate, pH 7.0 and samples of various 
urea concentrations above the concentration midpoint (𝐶A) in the same buffer. After five-minute 
incubation in an Applied Photophysics Chirascan equipped with a Quantum Northwest Inc. 
TC125 Peltier-controlled cuvette holder, we added the protein to the urea buffer, diluting the 
protein to a final concentration of 35 µg/mL, and manually mixed by inverting the cuvette. We 
then monitored the circular dichroism (𝐶𝐷) signal at 222 nm over time at 25°C in a one cm path 
length quartz cuvette. We measured the refractive indexes of each sample in order to the 
determine their precise urea concentration. An exponential was fit to each unfolding kinetic trace 
to determine the observed unfolding rate at that given urea concentration. The unfolding rate in 
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the absence of urea was then calculated using a linear extrapolation fit to the log of the observed 
unfolding rates as a function of urea. 
 
 
2.6.5 Activity Assays 
We measured the initial velocity (𝑣%) of antibiotic degradation by β-lactamase at 25°C via a 
change in absorbance (232 nm for benzylpenicillin, 262 nm for cefotaxime) using a Cary 100 
UV–Vis spectrophotometer (Agilent Technologies). The substrate (5-200 µM) was incubated at 
25°C for 5 min before addition of the protein. We diluted purified protein to a final concentration 
no greater than 200 nM. Our activity buffer was 50 mM potassium phosphate, pH 7.0 with 10% 
glycerol, and we measured each substrate concentration in triplicate. For benzylpenicillin, the 
Michaelis-Menton equation (below) was fit to the initial velocity as a function of the substrate 
concentration to determine individual catalytic rate (𝑘(<') and Michaelis constant (𝐾A) values. 
Here, [𝐸] is the total enzyme concentration, and [𝑆] is the total substrate concentration. For 
cefotaxime, the KM was too high to reach maximum velocity, so a line (below) with a slope equal 
to [𝐸] ∗ B!"#
C$
 was fit to the data. Error for the fit parameters was determined using bootstrapping. 
𝑣% =
[𝐸] ∗ 𝑘(<' ∗ [𝑆]
𝐾A + [𝑆]
	 (2.4) 
𝑣% = [𝐸] ∗
𝑘(<'
𝐾A
∗ [𝑆] (2.5) 
 
 
2.6.6 NMR CEST Experiments 
We recorded all experiments on a Bruker AVANCE III HD 18.8 T spectrometer equipped with a 
cryogenically cooled, x,y,z pulsed-field gradient triple-resonance probe. We recorded each D-
CEST [45, 46] experiment (30°C) as a pseudo-3D matrix, where each 2D spectrum were 
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obtained as a function of the position of weak B1 perturbations applied at discrete frequencies 
overt the chemical shift range of the probed nucleus. We applied a DANTE excitation scheme 
[47], which perturbs multiple regularly spaced frequencies at the same time, thereby decreasing 
the frequency range that must be explored over regular CEST approaches. In all cases, we 
calibrated the strength of the B1 field using a nutation experiment, as described previously [48].  
 
We acquired 15N D-CEST data as previously described [45] using 1 s DANTE excitation trains 
of square pulses (~7° flip angle, 2.5 kHz B1 field) and an interpulse delay of 2, 1, and 0.667 ms, 
resulting in effective B1 fields of about 10, 20, and 30 Hz. We sampled CEST profiles in 51 
steps, with increments of 10, 20, and 30 Hz, extending over frequency ranges of 500 (2 ms 
interpulse delay), 1000 (1ms), and 1500 Hz (0.667 ms), respectively. We extracted the position 
of the minor dips, exchange rate, and population of the excited state by fitting a two-state model 
of chemical exchange to the CEST data as described in detail previously [46]. Errors were 
estimated using the bootstrapping. 
 
 
2.6.7 NMR CPMG Experiments 
We recorded 15N CPMG experiments as previously described [49], using a constant-time 
relaxation interval, Trelax, of 30 milliseconds [50]. We sampled 20 νCPMG values of ≤1 kHz, using 
CPMG refocusing pulses applied at a γB1/2π = 6 kHz field and phase-modulated according to the 
{x,x,y,-y} cycling scheme [51]. We applied a γB1/2π = 15.6 kHz field 1H continuous wave 
decoupling during Trelax. To ensure constant heating in the reference experiments (recorded with 
Trelax equal to 0 seconds), we applied the same 1H continuous wave decoupling immediately prior 
to the recycle delay. 
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2.6.8 Molecular Dynamics Simulations and Analysis 
We prepared systems as previously described [20], using GROMACS software [52] and the 
Amber03 force field [53]. We solvated in TIP3P water [54] and energy minimized using the 
steepest descent algorithm. We used the V-rescale thermostat to maintain a fixed temperature of 
300K and the Berendsen barostat to bring the pressure up to one bar. Mutations were introduced 
into the starting structure using PyMol. 
 
We ran 200 nanoseconds of metadynamics simulations on each variant using the PLUMED 
plugin on GROMACS [55] and defined our collective variable (𝑠) using the backbone torsional 









Here, 𝜙% is the torsion angle of dihedral 𝑖 of the current frame in the simulation and 𝜙%
?;Dis a 
reference torsion angle defined by the corresponding dihedral in the crystal structure. This 
summation is done across 𝑛 dihedrals. We computed our collective variable using the 𝜙 and 𝜓 
angles of residues that underwent CEST, namely residues 237 through 243. Gaussians were 
added every 2 picoseconds with a height of 1.0 kJ/mol and a width of 0.05.  
 
We clustered our metadynamics simulations using a hybrid k-centers/k-medoids algorithm [56] 
to generate 220 representative seed conformations, using a cluster radius cutoff of 1.2 Å. We 
then used these conformations to collect a total of 100.7 microseconds of unbiased simulations 
on our Folding@home distributed computing platform [57]. 
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To analyze our simulation data, we first built a Markov state model (MSM) using our Enspara 
software [58]. We again clustered using a hybrid k-centers/k-medoids algorithm and used a 
cluster radius cutoff of 1.2 Å, which resulted in 9877 states. A pseudo-count was added to each 
element in the transition counts matrix to prevent sampling artifacts from influencing the 
transition probabilities. 
 
We then used the CARDS methodology [36] to compute the holistic communication (𝐼E(𝑋, 𝑌)) 
for every pair of dihedrals 𝑋 and 𝑌 using the equation below. 
𝐼E(𝑋, 𝑌) = 𝐼##(𝑋, 𝑌)]]]]]]]]]]] + 𝐼#F(𝑋, 𝑌)]]]]]]]]]]] +	𝐼F#(𝑋, 𝑌)]]]]]]]]]]] +	𝐼FF(𝑋, 𝑌)]]]]]]]]]]]]	 (2.7) 
Here, 𝐼##(𝑋, 𝑌)]]]]]]]]]]] is the normalized mutual information between the structure (i.e., rotameric state) 
of dihedral 𝑋	and the structure of dihedral 𝑌, 𝐼#F(𝑋, 𝑌)]]]]]]]]]]] is the normalized mutual information 
between the structure of dihedral 𝑋 and the dynamical state of dihedral 𝑌, 𝐼F#(𝑋, 𝑌)]]]]]]]]]]] is the 
normalized mutual information between the dynamical state of dihedral 𝑋 and the structure of 
dihedral 𝑌, and 𝐼FF(𝑋, 𝑌)]]]]]]]]]]]] is the normalized mutual information between the dynamical state of 
dihedral 𝑋 and the dynamical state of dihedral 𝑌. The mutual information (𝐼) is described by the 
equation below. 






Here, 𝑥	 ∈ 	𝑋 refers to the set of possible states that dihedral 𝑋 can adopt, 𝑝(𝑥) is the probability 
that dihedral 𝑋 adopts state 𝑥, and 𝑝(𝑥, 𝑦) is the joint probability that dihedral 𝑋 adopts state 𝑥 
and dihedral 𝑌 adopts state 𝑦. We computed normalized mutual information using the maximum 
possible mutual information, known as the channel capacity, for any specific mode of 
communication. We then computed a community network using affinity propagation [59], with a 
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damping parameter of 0.8. We generated the final allosteric network by filtering the community 
network using the Marginal Likelihood Filter (MLF) [60] to capture the top 5% of edges.  
 
Finally, we applied principal component analysis (PCA) to the distances between the Cβ atoms 
of every pair of residues in the community containing the Ω-loop and catalytic S70. We 
projected our MSM onto principal components 1 and 3 (PC1 and PC3) and pulled out exemplar 
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Chapter 3: Predicting Bacterial Fitness 




One strategy for closing the genotype-phenotype gap is to consider protein biophysics, as 
mutational effects can often be observed in measurable protein properties, and functional 
proteins are essential for organism fitness. However, it is still uncertain which protein properties 
contribute to fitness and to what magnitude. Here, I hypothesize that due to the multiple 
conformations a protein adopts and its complex biological context, both protein activity and 
stability are needed to predict fitness. To address my hypothesis, I investigated how the 
properties of TEM β-lactamase, a bacterial enzyme responsible for degrading β-lactam 
antibiotics, affect bacterial fitness as measured by minimal inhibitory concentration (MIC). I 
used a set of clinically prevalent TEM variants that increase bacteria resistance to the third-
generation cephalosporin cefotaxime. I found that protein activity alone, measured as catalytic 
efficiency, only explains 70% of the variance in MIC. By measuring TEM protein stability using 
three different signals, I found that TEM has a folding intermediate which is susceptible to 
proteolytic digestion. I reasoned that changes in the concentration of this intermediate lead to the 
changes seen in cellular protein abundance. As describing protein stability using fraction folded 
is insufficient to predict the abundance differences between variants, I derived an expression that 
describes the concentration of folded, active enzyme given the existence and proteolytic 
 65 
susceptibility of a folding intermediate. Ultimately, I found that my model explains 99% of the 




Disease often occurs because a mutation in a gene encoding a protein alters or disrupts that 
protein’s function. However, it is often unclear which mutations cause disease or the molecular 
mechanism in which the mutations exert their effects. In the simplest case, a mutation first 
changes the biophysical properties (e.g., activity and stability) of a singular protein and then 
those changes affect how well the protein functions and the organism survives. As mutations 
typically affect more than one biophysical property (pleiotropy) and their effects are dependent 
on the background protein sequence (epistasis) [1], it is difficult to predict the biophysical effects 
of a mutation. Furthermore, it is often unclear which proteins and which properties of the 
proteins significantly contribute to the fitness of the organism [2]. This problem in general is 
referred to as the genotype-phenotype gap (Figure 3.1). 
 
Figure 3.1. Protein biophysics links genotype to phenotype. Shown is a visual representation of how genotype 
and phenotype are related. A mutation is a change in genotype that can lead to a change in phenotype such as 
organism fitness. As mutations can affect the properties of a protein and how well a protein functions can be 
important for fitness, the biophysical properties of a protein can help bridge the genotype-phenotype gap. 
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As proteins link genotype and phenotype and have in vitro measurable properties, several of the 
previous successes towards closing the genotype-phenotype gap have focused on the biophysical 
properties of a protein essential for fitness [2-4]. However, proteins exist in often complicated in 
vivo contexts, and it is still unclear which in vitro properties of a protein can be used to predict 
fitness. In particular, it is unclear if protein stability contributes to fitness and how useful in vitro 
measurements of stability are in predicting fitness [5]. As proteins are dynamic molecules [6], I 
hypothesize that considering multiple protein conformations, along with the protein’s biological 
context, is necessary to close the genotype-phenotype gap. 
 
To address this hypothesis for one protein of interest, I consider how the biophysical properties 
of TEM β-lactamase lead to changes in E.coli fitness. As a naturally plasmid-encoded enzyme 
with a clear selective pressure, TEM β-lactamase is widely used to study molecular evolution [5, 
7-12]. TEM is a periplasmic enzyme that degrades and inactivates β-lactam antibiotics, such as 
penicillin. These antibiotics bind to penicillin binding proteins (PBPs), the proteins responsible 
for building and maintaining the cell wall. Without TEM, the β-lactam antibiotics inhibit PBPs 
and the cells burst [13]. Thus, TEM β-lactamase plays a singular, essential role in the cell.  
 
Here, I use the mutations E104K, M182T, and G238S, alone and in combination. These 
mutations are known to significantly increase bacterial resistance to the third-generation 
cephalosporin, cefotaxime, are three of the most clinically prevalent mutations, and have been 
seen clinically in all combinations [5]. As my measure of bacteria fitness, I use minimal 
inhibitory concentration (MIC) of cefotaxime. MIC is a discrete value and has been shown to be 
correlated with other measures of fitness, such as growth rate [11]. I then use the biophysical 
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properties of the TEM variants to predict fitness by determining the minimal set of properties 
that contribute to fitness, deriving a model for predicting fitness using those properties, and then 
testing my model with a set of new variants. 
 
 
3.3 Results and Discussion 
3.3.1 Catalytic Efficiency is Not Sufficient to Predict Bacterial Fitness 
I aimed to determine the minimal number of protein biophysical properties that are necessary to 
predict bacterial fitness. Accurate prediction would demonstrate our understanding of the protein 
properties that contribute to fitness and that ultimately describe the molecular context for 
mutations. As β-lactamase function is essential for survival in the presence of antibiotics, I began 
with the hypothesis that TEM β-lactamase catalytic efficiency (𝑘!"# 𝐾$⁄ ) alone is sufficient to 
predict MIC. 
 
Nikaido and Normark in 1987 proposed, and subsequently showed, that MIC values could be 
accurately predicted by combining the expression for the diffusion of the antibiotic across the 
outer membrane (Fick diffusion) with the expression describing the hydrolysis of the antibiotic 
by β-lactamase enzymes (Michaelis-Menten) [14]. Their model is given below. 
𝑀𝐼𝐶 = 	 [𝑆]%&#'"% +	
[𝑆]%&#'"% ∗ 	𝑘!"# ∗ [𝑁]
𝑃 ∗ 𝐴 ∗ (𝐾$ + [𝑆]%&#'"%)
	 (3.1) 
Here [𝑆]%&#'"% is the concentration of antibiotic needed to kill the cells (based on antibiotic 
binding to essential PBPs) [14], and [𝑁] is the concentration of natively folded protein. 𝑘!"# and 
𝐾$ are the catalytic rate and Michaelis constant, respectively, determined from Michaelis-
Menten kinetics. 𝑃 is the outer membrane permeability to the antibiotic, and 𝐴 is the surface area 
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of the cell. Nikaido and Normark predicted MIC by measuring the 𝑣(") (equal to 𝑘!"# ∗ 	 [𝑁]) of 
β-lactamases from cellular extracts [14]. However, if we follow Knies, Cai, and Weinreich and 
assume that [𝑁] is constant because TEM and its variants are stable (>99% folded) and that 
𝐾$ ≫ [𝑆]%&#'"%, the model can be simplified to the one shown below [5]. 




𝑍 includes [𝑆]%&#'"%, [𝑁], 𝑃, and 𝐴, which are all assumed to be independent on the TEM variant 
being produced, and thus my expression for MIC depends only on properties of TEM that can be 
measured in vitro. 
 
To test my hypothesis, I produced and purified each TEM variant from E. coli to measure the 
catalytic efficiency against cefotaxime using Michaelis-Menten kinetics (Table 3.1). I then 
measured the minimal inhibitory concentration of bacteria producing each TEM variant in the 
presence of cefotaxime under the native TEM promoter and signal sequence (Table 3.1). Finally, 
I predicted the MIC values from the catalytic efficiencies by fitting the single 𝑍 parameter, which 
I found to be 31 ± 6 µM2sec. 
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Figure 3.2. Catalytic efficiency accounts for 70% of the variance in minimal inhibitory concentration (MIC). 
Catalytic efficiency was measured for each TEM variant using Michaelis-Menten kinetics. Using a single parameter 
to account for TEM-independent factors, MIC was predicted (y-axis) and correlated to experimental MIC (x-axis). 
The dashed line represents a perfect 1:1 correlation. 
 
I found that catalytic efficiency alone predicts only 70% of the variance in MIC (Figure 3.2). As 
expected, there is a strong correlation (R2 = 0.7 ± 0.1) between catalytic efficiency and MIC. 
However, I also found that a large increase in fitness could be achieved without a corresponding 
increase in activity. TEM E104K/G238S has a catalytic efficiency of 3.0 ± 0.1 sec-1µM-1 and a 
MIC of 36 µM, while TEM E104K/M182T/G238S has a similar catalytic efficiency of 3.13 ± 
0.09 sec-1µM-1 but a much higher MIC of 144 µM. Thus, my results suggest that another 
property significantly contributes to bacterial fitness. This result is not surprising given that TEM 
mutations are known to display epistasis (non-additivity) in their fitness effects, leading to a 





3.3.2 Changes in Thermodynamic Protein Stability Have Cellular 
Consequences 
As beneficial mutations typically increase fitness by either increasing protein activity or 
increasing the concentration of properly folded protein in the cell, and cellular protein abundance 
is modified by thermodynamic stability [3], I hypothesized that TEM stability significantly 
contributes to bacterial fitness. In agreement with this hypothesis, previous work by Jacquier et 
al. found that 29% of the variance in MIC could be predicted by TEM stability alone, suggesting 
that combining TEM catalytic efficiency and stability should theoretically account for 99% of 
the variance in MIC. Wild-type TEM, however, is very stable (in vitro global thermodynamic 
stability of -14.3 ± 0.3 kcal/mol) [5, 16], and it has been previously shown that measurements of 
thermostability do not aid in the prediction of MIC [5]. That being said, stability values are likely 
different in vivo than in vitro because different protein conformations have different likelihoods 
of aggregating, degrading, and interacting with other cellular components. I hypothesized that 
changes in stability have physiological consequences that can be modeled using in vitro stability 
measurements. 
 
I first measured TEM stability of my purified protein using three independent signals: (i) circular 
dichroism (CD) reporting on α-helical secondary structure, (ii) intrinsic tryptophan fluorescence 
reporting on the change in the environment of aromatic residues, and (iii) gel band intensity after 
pulse proteolysis reporting on proteolytic conformations. I used urea as a chemical denaturant in 
all three experiments, determined free energy differences using a linear extrapolation model (see 
Methods), and compared each measurement using fraction folded. 
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As shown previously, I found that TEM does not fold in a two-state manner (Figure 3.3a). An 
intermediate population can be observed from the CD experiments. When monitored via 
fluorescence, unfolding appears two-state, but transitions at a urea concentration near the first 
transition seen by CD. In fact, I have previously globally fit to CD and fluorescence data using a 
three-state model to extract stability values for each transition. Furthermore, when I monitor 
stability using pulse proteolysis experiments, I find that the folding transition overlays well with 
the fluorescence data. These data suggest that TEM folds via at least a three-state mechanism. 
Fluorescence and pulse proteolysis report on the same transition from the native to the 
intermediate populations, suggesting that the intermediate population is proteolytically 
susceptible. 
 
As I found that fluorescence reports on the first (lowest energy) visible folding transition, I 
measured the stability using this method for each of the TEM variants (Table 3.1). Strikingly, I 
found that the two variants highlighted above, TEM E104K/G238S and TEM 
E104K/M182T/G238S, have very different stabilities (Figure 3.3b). This might explain their 
differences in MIC values, as TEM E104K/M182T/G238S has both a larger stability and a larger 




Table 3.1. Catalytic efficiency (kcat/KM), thermodynamic stability (ΔGN↔I), and minimal inhibitory 
concentrations (MIC) for TEM variants used to determine the properties which contribute to fitness. 
 
 
To test whether a stability change of about 3 kcal/mol can alter cellular protein abundance, I 
produced TEM variants in E. coli under the native TEM promotor and signal sequence. Then I 
lysed the cells and separated proteins using gel electrophoresis. Gel samples were normalized by 
total protein concentration as measured via a Bradford assay. I visualized only the bands 
corresponding to TEM by performing a Western blot with TEM primary antibodies. As a test 
case, I measured the cellular protein abundance of wild-type TEM and the two variants that 
displayed the lowest in vitro stabilities, TEM G238S (ΔGN↔I = -3.6 ± 0.2 kcal/mol) and TEM 
E104K/G238S (ΔGN↔I = -3.0 ± 0.3 kcal/mol).  






Figure 3.3. Decreased stability decreases cellular protein abundance. A) Wild-type TEM folding/unfolding was 
monitored using circular dichroism (blue circles), intrinsic tryptophan (Trp) fluorescence (orange triangles), and 
band intensity after pulse proteolysis (gray pentagons). Fraction folded is shown as a function of urea concentration 
for each representative experiment. Free energy values were determined from three independent experiments and fit 
using a linear extrapolation model. Fits are shown as solid lines in corresponding colors. B) Stability was measured 
via fluorescence for TEM E104K/G238S (blue circles) and TEM E104K/M182T/G238S (orange triangles). Fraction 
folded is shown as a function of urea concentration for each representative experiment. Free energy values were 
determined from three independent experiments and fit using a linear extrapolation model. Fits are shown as solid 
lines in corresponding colors. C) Cellular protein abundance was measured for whole cell lysate (WCL) and soluble 
fractions using a Western blot with anti-TEM antibodies. The molecular weights of the pre-stained protein ladder are 
shown on the left. Bands can be seen at the expected molecular weight for wild-type TEM (WT TEM) but not for 
TEM G238S (G238S) or TEM E104K/G238S (E104K/G238S). D) Shown is the kinetic scheme used to derive my 
model describing minimal inhibitory concentration. U, I, and N are the unfolded, intermediate, and native states, 
respectively. Their rates of folding and unfolding are described using the same convention. ksyn is the synthesis rate, 
and kprot is the proteolysis rate. 
 
Table 3.3. Destabilized variants have lowered cellular protein abundance than wild-type TEM. 
 
 
I found that my destabilized variants displayed drastically reduced cellular abundance (Figure 
3.3c). Clear bands were visible for wild-type TEM from both the whole cell lysate and soluble 
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samples. However, no bands were visible for TEM G238S or TEM E104K/G238S despite 
confirmed antibody binding (Figure 3.4). This is likely due to protein cellular abundance levels 
below the detection limit of my experiment as both of these variants have higher MIC values 
than wild-type TEM and lowered abundance was quantified using an independent assay (Table 
3.3). Decreased thermodynamic stability likely decreased cellular protein abundance by either 
causing the protein to aggregate or be degraded. As the whole cell lysate and soluble samples 
display similar intensities for each variant, and I showed above that the intermediate population 
is susceptible to proteolytic digestion (Figure 3.3a), I reasoned that TEM variants with decreased 
stabilities displayed lowered cellular abundance due to their larger populations of the 
intermediate being degraded by proteases. This appears to be true despite the percent of 
intermediate population in vitro calculated to be < 1%. 
 
Figure 3.4. The monoclonal TEM primary antibody binds to purified TEM G238S and TEM E104K/G238S. 
While no antibody binding is detected with cell lysate samples after protein expression, the antibody is shown to 




3.3.3 My Model Predicts Bacterial Fitness from Biophysical Properties 
As I showed above that protein stability affects protein abundance in the cell, but that differences 
in fraction folded between my variants are very small, I derived a different expression for 
stability that could be used in my model. I first allowed [𝑁] to depend on the TEM variant 
produced and considered a three-state folding mechanism where TEM is first synthesized to an 
unfolded state, U, folds to an intermediate state, I, and then proceeds to a native state, N (Figure 
3.3c). Besides the folding (𝑘*→, and 𝑘,→-) and unfolding rates (𝑘,→* and 𝑘-→,), TEM can also 
be synthesized with a rate 𝑘./0 and degraded from the intermediate state with a rate 𝑘123#. I 
assumed the concentration of U to be negligible, that 𝑘./0 and 𝑘123# are independent of the TEM 
variant produced, and that [𝑁] reaches steady-state. This resulted in the expression for MIC 
given below. 






Δ𝐺-↔, is the free energy difference between the native and intermediate populations, 𝑅 is the gas 
constant, and 𝑇 is temperature.  
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Figure 3.5. M182T has comparable cellular protein abundance as wild-type (WT) TEM. Cellular protein 
abundance was measured using a Western blot with anti-TEM antibodies. The molecular weights of the pre-stained 
protein ladder are shown on the left. Similar intensity bands can be seen at the expected molecular weight for wild-
type TEM (WT TEM) and TEM M182T (M182T). The bands are also comparable between the whole cell lysate 
(WCL) and soluble samples. 
 
I then predicted MIC using the measured values in Table 1 and by fitting the 𝑍4 parameter. I also 
fit an additional parameter which describes a stability threshold. Practically, this parameter 
results from the assumption that increased stability past a certain threshold does not increase 
fitness. This is based on the observation that the M182T mutation has comparable fitness (Table 
3.1) and cellular abundance (Figure 3.5) to wild-type TEM despite increasing stability by about 4 
kcal/mol. Stabilizing mutations have also been shown in general to be neutral alone but 
beneficial when they compensate for activating, destabilizing mutations [10]. Mathematically, 




Figure 3.6. Considering both activity and stability predicts 99% of the variance in minimal inhibitory 
concentration (MIC) values. By fitting a single parameter to account for TEM-independent factors and a threshold 
parameter to account for diminishing stability effects, MIC was predicted (y-axis) and correlated to experimental 
MIC (x-axis). Parameters were fit using the data shown as blue circles and validated using the data shown as orange 
triangles. The dashed line represents a perfect 1:1 correlation. 
 
I found that my model predicted 99% of the variance (R2 = 0.9999 ± 0.0003) in MIC (Figure 3.6, 
blue circles). Strikingly, consideration of stability resulted in both TEM E104K/G238S and TEM 
E104K/M182T/G238S to fall on the 1:1 correlation line. In the case of TEM beta-lactamase, I 
found that activity accounts for 70% of the variance in MIC and stability accounts for 29%, in 
agreement with previous work [11]. The value of my 𝑍′ parameter was 0.078 ± 0.001 and my 
threshold was -3.781 ± 0.009 kcal/mol. If I consider that wild-type TEM may actually only have 
1.7 kcal/mol stability in vivo [11], this would mean that my in vitro stability measurements are 
over-estimating stability by about 4.3 kcal/mol. My fit threshold was similar to this value and 
using a -4.3 kcal/mol threshold yields similar results (Figure 3.7). 
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Figure 3.7. Using a threshold value of -4.3 kcal/mol explains 98% of the variance in minimal inhibitory 
concentration (MIC). MIC was predicted (y-axis) and correlated to experimental MIC (x-axis) using my model that 
considers both protein activity and stability. I used the previously fit (main text) 𝑍4 parameter and a value of -4.3 
kcal/mol as my threshold value. The dashed line represents a perfect 1:1 correlation. Error in the correlation was 
determined using bootstrapping. 
 
Encouraged by these results, I next aimed to validate my model with a set of new TEM variants. 
I was interested to see if my model would be generalizable to non-clinical mutations, so I 
selected the A42G mutation, alone and in combination with my other single mutants. A42G, in 
contrast to my other mutations, is not known to be clinically important, was instead identified 
during an in vitro evolution experiment, and has also been much less studied. This mutation 
appears to be relatively neutral in the wild-type background, but displayed positive epistasis 
when in combination with the other three mutations studied here.  
Table 3.4. Catalytic efficiency (kcat/KM), thermodynamic stability (ΔGN↔I), and minimal inhibitory 




Given the activity and stability measurements of the new TEM variants (Table 3.2) and using the 
same values for 𝑍4 and the threshold that were fit above, I found that my model was able to 
accurately predict MIC values (Figure 3.6, orange triangles). Specifically, I found the correlation 
for all variants to be R2 = 0.99 ± 0.04. In summary, my results show that both protein activity 
and stability are necessary for predicting bacterial fitness, suggesting that these properties 




I aimed to predict E. coli bacterial fitness using the biophysical properties of TEM β-lactamase. I 
found that catalytic efficiency alone was not sufficient to explain the variance in MIC, 
particularly because a large gain in MIC could be achieved without a corresponding change in 
catalytic efficiency. I next considered the role of protein stability in fitness. I measured stability 
using three independent signals and found that a < 3 kcal/mol destabilization between the native 
and proteolytically susceptible intermediate populations in vitro was enough to drastically reduce 
protein abundance in vivo. This finding provides evidence for the importance of higher energy 
protein states in determining cellular protein concentrations and ultimately organism fitness. 
Finally, I derived a model for predicting MIC using in vitro activity and stability measurements 
of TEM and found that I could predict 99% of the variance in MIC. The exact values of my fit 
parameters are likely to be improved upon as more TEM variant data is collected. However, 
overall, my results demonstrate my understanding of the protein biophysical properties which 
contribute to fitness, and I expect my model to be generalizable to other β-lactam antibiotics.   
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3.5 Methods 
3.5.1 Mutagenesis and Protein Purification 
I previously cloned the gene for TEM-1 β-lactamase into a pET24-b plasmid (Life Technologies) 
with kanamycin resistance and OmpA signal sequence for inducible protein expression under the 
T7 promoter [17]. I generated protein variants using site-directed mutagenesis and verified the 
mutations via DNA sequencing. I then produced and purified TEM variants as previously 
described [17]. Briefly, I transformed my desired plasmid into BL21(DE3) cells (Intact 
Genomics), grew cultures to an OD600 of 0.6, and induced protein production with 1 mM IPTG. I 
expressed overnight at 18°C before purifying TEM from the periplasm using osmotic shock. I 
harvested cells and equilibrated them first in 30 mM Tris, pH 8.0 with 20% sucrose at room 
temperature and then in 5 mM MgSO4 at 4°C. I next dialyzed the supernatant against 20 mM 
sodium acetate, pH 5.5 overnight at 4°C in preparation for purification the next day using cation 
exchange chromatography (BioRad UNOsphere Rapid S column) with an NaCl gradient. Finally, 
I performed size exclusion chromatography (BioRad ENrich SEC 70 column) and stored the 
purified protein at 4°C in 20 mM Tris, pH 8.0. 
 
 
3.5.2 Activity Assays 
Catalytic efficiency was measured as described previously [18]. Briefly, I monitored the 
degradation of cefotaxime by TEM at 25°C via a change in absorbance at 262 nm using a Cary 
100 UV–Vis spectrophotometer (Agilent Technologies) in 50 mM potassium phosphate, pH 7.0 
with 10% glycerol. The final protein concentration was no greater than 200 nM. 5-200 µM 
cefotaxime was incubated at 25°C for 5 min before addition of the protein, and I measured each 
cefotaxime concentration in triplicate. When possible, the Michaelis-Menton equation (below) 
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was fit to the initial velocity (𝑣=) as a function of the substrate concentration [𝑆] to determine 
individual catalytic rate (𝑘!"#) and Michaelis constant (𝐾$) values. Here, [𝐸] is the total enzyme 
concentration. 
𝑣= =
[𝐸] ∗ 𝑘!"# ∗ [𝑆]
𝐾$ + [𝑆]
	 (3.4) 
When the KM was too high to reach maximum velocity, a line (below) with a slope equal to [𝐸] ∗
>$%&
?'
 was fit to the data. Error for the fit parameters was determined using bootstrapping.  
𝑣= = [𝐸] ∗
𝑘!"#
𝐾$
∗ [𝑆] (3.5) 
 
 
3.5.3 Urea Denaturation Experiments 
For both fluorescence and CD experiments, I prepared samples of 35 µg/mL protein in 50 mM 
potassium phosphate, pH 7.0 at various concentrations of urea and equilibrated the samples at 
room temperature overnight. After one-minute incubation in the instrument, I performed 
experiments as previously described [16, 18]. I recorded the signal at 25°C in a one cm path 
length quartz cuvette and measured the refractive indexes of each sample afterward in order to 
the determine their precise urea concentration.  
 
To monitor fluorescence (𝐹) emission at 340 nm, I used a Jasco FP-8300 spectrofluorometer 
equipped with a Peltier-controlled cuvette holder. To monitor circular dichroism (𝐶𝐷) signal at 
222 nm, I used an Applied Photophysics Chirascan equipped with a Quantum Northwest Inc. 
TC125 Peltier-controlled cuvette holder. I determined free energy values by fitting a two-state 
folding model (below) to the fluorescence data and a three-state folding model (below) to the CD 
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data using the linear extrapolation method [19]. Each variant was measured in triplicate 
experiments. 
𝐹 = 	
𝐹* +	𝐹- ∗ 𝑒5(67A(∗[C2&"]) 8∗:⁄
1 +	𝑒5(67A(∗[C2&"]) 8∗:⁄
	 (3.6) 
Here, 𝐹* and 𝐹- are the fluorescence signals for the unfolded and native states, fit as lines.		Δ𝐺 is 
the extrapolated free energy difference between the unfolded and native states in the absence of 
urea, and 𝑚 is the proportionality constant related to the steepness of the folding transition. 𝑅 is 
the gas constant, and 𝑇 is temperature. 
𝐶𝐷 =	
𝜃( +	𝜃) ∗ 𝑒*(,-!↔#./!↔#∗[2345]) 8∗9⁄ +	𝜃; ∗ 𝑒*(,-$↔!./$↔!∗[2345]) 8∗9⁄ ∗ 𝑒*(,-!↔#./!↔#∗[2345]) 8∗9⁄
1 +	𝑒*(,-!↔#./!↔#∗[2345]) 8∗9⁄ +	𝑒*(,-$↔!./$↔!∗[2345]) 8∗9⁄ ∗ 𝑒*(,-!↔#./!↔#∗[2345]) 8∗9⁄
	 (3.7) 
Here, 𝜃*, 𝜃, and 𝜃- are the CD signals for the unfolded, intermediate, and native states, fit as 
lines.		Δ𝐺*↔, and Δ𝐺,↔- are the extrapolated free energy difference between the unfolded and 
intermediate states and the difference between the intermediate and native states, respectively. 
𝑚*↔, and 𝑚,↔-  are the proportionality constants related to the steepness of the two folding 
transitions. Again, 𝑅 is the gas constant, and 𝑇 is temperature. 
 
For the pulse proteolysis experiments [20], I equilibrated samples of 0.5 mg/mL TEM in 20 mM 
Tris, pH 7.0 plus 10 mM CaCl2 and various concentrations of urea at room temperature 
overnight. Then, I added 0.05 mg/mL of thermolysin (Promega) to each tube and vortexted 
briefly. Thermolysin is active in urea concentrations up to 7 M and was stored in 2.5 M NaCl and 
10 mM CaCl2 [20]. After 1 minute, I removed an aliquot of each reaction and added it to a tube 
with 50 mM EDTA to quench the proteolytic reaction. I then separated the samples using SDS-
PAGE, stained the gel with SyproRed in 7.5% acetic acid, and imaged the gel usinga Typhoon 
FLA 7000 biomolecular imager (GE). Finally, I quantified the gel band intensities using ImageJ 
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(Fiji) and fit a two-state folding model (as shown above) to the proteolysis data, using the value 
for 𝑚 determined from the fluorescence experiments. 
 
 
3.5.4 Calculation of Fraction Folded 





Δ𝐺-↔, is the free energy difference between the intermediate and native states determined from 
fluorescence experiments. 𝑅 is the gas constant, and 𝑇 is temperature. 
 
 
3.5.5 Protein Abundance Using Western Blotting 
First, I first generated TEM variants in the pBR322 plasmid using site-directed mutagenesis, 
verified the mutations via DNA sequencing, and transformed plasmids into DH5α cells (Life 
Technologies). I also used these plasmids in the MIC experiments as they use tetracycline 
resistance for selection, the native TEM promoter for constitutive protein expression, and the 
native TEM signal sequence for periplasmic export. I grew 5 mL liquid cultures to saturation 
before harvesting cells and resuspending them in 20 mM Tris, pH 7.0 plus Roche protease 
inhibitors. Next, I lysed cells using freeze thaw cycles followed by sonication. I then quantified 
the total concentration of protein in each sample using a Bradford assay and made samples with 
equal amounts of total protein to separate via SDS-PAGE. 
 
I transferred the protein to a polyvinylidene fluoride (PVDF) membrane (Bio-Rad) at 4°C in 25 
mM Tris base, 192 mM glycine, 20% (v/v) ethanol. After transfer was complete, I equilibrated 
membranes first in methanol then in Tris buffered saline Tween-20 (TBST) supplemented with 
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5% (w/v) powdered dry milk (PDM) for 5 minutes. I added a 1:2,000 dilution of mouse β-
lactamase primary monoclonal antibody (ThermoFisher) to the TBST/5% PDM solution and 
incubated 45 minutes while rocking. I washed the membrane with TBST three times to remove 
unbound antibody and then incubated for 45 minutes with a 1:10,000 dilution of rabbit anti-
mouse IgG/IgM alkaline phosphatase (AP)-conjugated polyclonal secondary antibody 
(ThermoFisher) in TBST/5% PDM while rocking. Again, I washed the membrane three times 
with TBST to remove unbound antibody and then rinsed twice with deionized water. Finally, I 
developed the membrane by incubating it with alkaline phosphatase buffer (100 mM Tris HCl, 
pH 9.5, 100 mM NaCl, 5 mM MgCl2) containing nitro blue tetrazolium and 5-bromo-4-chloro-3-
indoyl-phosphate (Promega), until bands turned dark purple. I stopped the reaction by rinsing 
with water and left the membranes to dry overnight before imaging. 
 
 
3.5.6 96-well Plate Assay for Protein Abundance  
I used the same plasmids, cells, and cell lysis protocol as the protein abundance measurements 
via Western blots described in the main text methods. Again, I measured the total cellular protein 
abundance using a Bradford assay. Instead of running a gel, however, I calculated the β-
lactamase concentration in the cells by measuring the rate of hydrolysis of (300 µM) nitrocefin 
(Cayman Chemical) by the cell lysates. I included buffer only (50 mM potassium phosphate, pH 
7.0) samples and a dilution series of purified protein in my 96-well plate. I next generated 
dilution series of cell lysates, of cells both with and without the plasmid containing β-lactamase. 
I then used a Synergy2 plate reader (BioTek) equipped with an injector in order to add an equal 
volume of nitrocefin to each well and immediately measure the change in absorbance at 482 nm 
for 30 seconds at 25°C. 
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To calculate the protein concentration, I first calculated the slope of the linear signal from each 
well of my plate. I then plotted the slope as a function of known protein concentration for my 
wells containing purified protein. This allowed us to obtain an in-plate determination of the 
relationship between absorbance signal and protein concentration, as the different variants have 
different catalytic rates for nitrocefin. I then divided the calculated slope from each of my cell 
lysate wells with the slope from my purified protein standard curve and converted this value to 
mg/mL. After accounting for the dilution factor for each well and normalizing by total cellular 
protein abundance, I report the average protein abundance and standard deviation for each 
experimental well within the dynamic range. 
 
 
3.5.7 Minimal Inhibitory Concentration Measurements 
I transformed plasmids into DH5α cells and grew 5 mL liquid cultures to saturation. I then 
diluted cells to an OD600 of 0.0003 in sterile Mueller Hinton II (MHII) media broth (Sigma). As 
previously [16], to determine the minimal inhibitory concentrations of cefotaxime, I used the 
broth microdilution method. I used water with no antibiotic in one row for a positive control for 
cell growth and used the antibiotic gentamicin in another row for a negative control for cell 
growth. I prepared 20 mM cefotaxime by dissolving the compound in water, prepared 
cefotaxime dilutions in MHII, and added these to the first well of each remaining row in a 96-
well round-bottomed plate. I then made two-fold serial dilutions across each row. Finally, I 
added a volume of bacteria culture equal to the antibiotic volume in the plate to each well and 
incubated the plate at 37ºC for 17 hours. I determined MIC as the lowest concentration of 
cefotaxime that inhibited cell growth as judged by visual inspection of turbidity. 
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Chapter 4: Conclusion and Future Directions 
 
4.1 Excited States Containing a Cryptic Pocket Can Play a 
Functional Role  
Cryptic pockets have been discovered in many different systems [1-3], but because they are 
difficult to observe, it has been unclear if cryptic pocket opening is generally conserved. While it 
has been proposed that cryptic pockets could provide a means to achieve homolog- or isoform-
specific therapeutics [4], this has yet to be rigorously tested. In Chapter 2, we found that neither 
MTB nor GNCA opened a pocket in the region of the Ω-loop cryptic pocket in TEM, suggesting 
that the thiol labeling technique used is an unbiased method for searching for cryptic pockets. 
This result also shows that the Ω-loop cryptic pocket is not conserved across β-lactamase 
homologs despite the homologs sharing the same topology. However, the protein sequences were 
different, suggesting the importance of sequence in determining cryptic pocket opening. 
 
We also found that homologs with Ω-loop pockets were able to better hydrolyze benzylpenicillin 
as compared to homologs without pockets. Furthermore, by focusing the remainder of our study 
on TEM β-lactamase, we found that variants with higher populations of open Ω-loop pockets 
were also able to better hydrolyze benzylpenicillin. These increases in catalytic efficiencies were 
mostly due to increases in catalytic rate, suggesting a role in Ω-loop dynamics in the hydrolysis 
mechanism. Combining these results with previous work that demonstrated a correlation between 
cefotaxime activity and the population of closed Ω-loop conformations [5], we hypothesized that 




In order to gain structural insight, we examined the dynamics of TEM β-lactamase using NMR 
chemical exchange saturation transfer (CEST) experiments [6]. CEST allows us to observe 
excited states in proteins that have populations as small as 1% or less and does not require a 
cysteine mutation. Thus, these experiments can nicely corroborate findings from thiol labeling 
experiments. For TEM, we found that an excited state is present in the native ensemble and that 
the residues that contributed to the exchange between the ground and excited state were mostly 
in the region of the Ω-loop pocket. Furthermore, the population of the excited state determined 
from CEST experiments matched the population determined from thiol labeling, and when the 
Ω-loop pocket was removed from TEM, the dynamics monitored via CEST disappeared. We 
next ran NMR-guided molecular dynamics simulations that seeded unbiased simulations. This 
strategy allowed us to observe cryptic pocket opening and obtain detailed structures of the pocket 
open and closed states. Taken together, these results suggest that excited states containing cryptic 
pockets can be observed using thiol labeling, NMR CEST, and molecular dynamics, which 
expands our ability to investigate these excited states in any system. 
 
Our model that an open Ω-loop pocket is beneficial for benzylpenicillin activity but detrimental 
to cefotaxime activity is in contrast with the hypothesis that cefotaxime activity requires an 
expansion of the active site due to the substrate’s increased size compared to benzylpenicillin 
[7]. If the latter hypothesis were true, one would expect that opening the Ω-loop pocket would 
increase cefotaxime activity and decrease benzylpenicillin activity while the opposite would be 
true for our proposed model. To explicitly test the effects of pocket dynamics on activity, we 
designed mutations which either enhanced or suppressed Ω-loop pocket opening. We found that 
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there was a clear positive correlation between Ω-loop pocket opening and benzylpenicillin 
activity, suggesting that an open Ω-loop pocket is beneficial for benzylpenicillin activity. 
Furthermore, we also found that a closed Ω-loop pocket is beneficial for cefotaxime activity, 
despite being a larger substrate. 
 
In summary, our results suggest that excited states containing a cryptic pocket can play a role in 
protein function. This suggests that they may be favored by natural selection, making cryptic 
pockets more tractable drug targets. If a protein cannot easily evolve away cryptic pocket 
opening because it is important for function, it will be more difficult to evolve resistance to a 
drug which binds a cryptic pocket. The functional role of excited states containing a cryptic 
pocket also suggests that the use of pocket opening and excited states in general may be more 
prevalent in molecular mechanisms than we currently realize. Overall, this work demonstrates 
the utility of excited states containing cryptic pockets and provides evidence for their continued 
study. 
 
4.2 Limitations of our Work Investigating Cryptic Pockets. 
As with any scientific study, there are limitations to our analyses and interpretations. For 
example, our analysis of cryptic pocket conservation was limited to one representative sequence 
from each β-lactamase homolog family. So, we cannot say if other MTB sequences in fact do 
contain the Ω-loop pocket or if other TEM and CTX-M sequences do not contain the Ω-loop 
pocket. Furthermore, our analysis was limited to one cryptic pocket in class-A β-lactamases. 
Future studies may investigate the conservation of cryptic pockets in other systems and using a 
larger number of sequences. Additionally, our labeling assays provide a quantitative description 
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of pocket opening but do not provide a full characterization of the protein energy landscape. 
Thus, there may be important protein motions that contribute to activity that are not visible by 
monitoring cysteine labeling. These dynamics could be larger scale motions such as surface loop 
movements or smaller scale motions such as different sidechain rotamers. As a consequence, the 
population of the open cryptic pocket conformations is correlated with benzylpenicillin activity 
and is a predictive signature, but we cannot say that there is a causal link between the two. 
 
4.3 Future Studies to Elucidate the Functional Role, 
Sequence Determinants, and Cooperativity of Cryptic 
Pocket Opening 
4.3.1 Elucidate the Sequence Determinants of Cryptic Pocket Opening 
We found that four β-lactamase homologs with the same topology but different sequences had 
different open Ω-loop cryptic pocket populations. Despite sharing the same overall fold and 
containing the Ω-loop structural motif, two of the class-A β-lactamase homologs, MTB and 
GNCA, did not open a pocket in the region of the Ω-loop pocket in TEM and CTX-M-9. 
Furthermore, a singular R241P mutation was able to remove the Ω-loop pocket in TEM 
completely. These results suggest sequence is important for determining cryptic pocket opening, 
but it is still unclear what the sequence determinants for pocket opening are. 
 
Figure 4.1. TEM and GNCA β-lactamases share 67% sequence identity in the region of the Ω-loop pocket. 
The regions of the Ω-loop and 238-loop are underlined. The positions where the two sequences differ are 
highlighted in yellow.  
 
GNCA does not have an Ω-loop cryptic pocket but is the ancestor sequence for TEM β-
lactamase [8], which has the highest population of open Ω-loop pocket for the homologs tested. 
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These two homologs also have similar sequences around the Ω-loop pocket region, sharing 67% 
sequence identity and 78% sequence similarity (Figure 4.1). To better understand the sequence 
determinants of cryptic pocket opening, I propose determining the minimal set of TEM-like 
mutations needed to open the Ω-loop pocket in GNCA. 
 
There are six TEM-like mutations that could be made in GNCA in the Ω-loop region: A173I, 
G175N, P177E, G240E, H241R, and T243S (Figure 4.1). I propose incorporating each mutation 
into GNCA individually and testing the effects of the mutation on thiol labeling. The two 
mutations with the most potential are P177E and G240E. P177E would remove a proline residue 
in the Ω-loop of GNCA, which would likely increase its conformational freedom. We found that 
adding in a proline residue into the Ω-loop pocket of TEM (R241P) removed the pocket, so I 
reason that the opposite is likely true for GNCA. However, there is a proline residue at position 
177 in CTX-M-9 that does open an Ω-loop pocket, suggesting that broader sequence context may 
also be important.  
 
G240E, on the other hand, would add a negatively charged residue in the Ω-loop region of 
GNCA right across from the glutamic acid at position 171. I reasoned that this may destabilize 
the closed pocket conformation and promote pocket opening. However, I did test this mutation 
and found that the Ω-loop pocket does not open in GNCA G240E (Figure A.4). 
 
If a single mutation is unable to open the Ω-loop pocket in GNCA, mutations could be 
incorporated in combination. However, with 6 mutations, there are 26 = 64 possible 
combinations. Using the data from Stiffler et al. [9], we can see which of the GNCA-like 
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mutations in TEM increased fitness in the presence of cefotaxime. These mutations likely close 
the Ω-loop pocket in TEM, so the opposite mutations might open the Ω-loop pocket in GNCA. 
The two mutations that meet this criterium are A173I and G240E, suggesting the prioritization of 
the single mutant A173I and the double mutant A173I/G240E. Alternatively, molecular 
dynamics simulations, and particularly those run with the enhanced sampling algorithm FAST 
pockets [10], could be used to select variants to experimentally test. 
 
Elucidating the sequence determinants of cryptic pocket opening has important implications in 
protein design as it would increase our understanding of how mutations change not only the 
ground structure of a protein but its relative populations of excited state structures. As we 
showed in Chapter 2, protein excited states can be functionally relevant, and future design efforts 
will likely design towards an ideal protein energy landscape rather than one ideal protein ground 
state structure [11]. Understanding sequence determinants will also be useful in the prediction of 
which homologs or isoforms contain cryptic pockets and would allow for the design of more 
specific therapeutics that target cryptic pockets [4, 12]. 
 
 
4.3.2 Determine if the Open Ω-loop Pocket Population is Correlated to an 
Individual Rate Constant in the β-lactamase Catalytic Mechanism 
We found that β-lactamase homologs which open an Ω-loop pocket have higher overall catalytic 
rates (kcat) against benzylpenicillin than homologs which do not open an Ω-loop pocket. We also 
found that for TEM variants, the open Ω-loop pocket population is correlated with the catalytic 
rate for hydrolysis of benzylpenicillin. However, TEM-1 β-lactamase hydrolyzes 
benzylpenicillin with an efficiency near the diffusion limit, meaning that the individual rate 
 94 
constants for the reaction are fast and comparable to one another [13]. This leads to an overall 
catalytic rate that is described by multiple rate constants. 
 
Hydrolysis of β-lactams by β-lactamase follows the reaction scheme shown below. 
 
𝐸 + 𝑆	 ↔ 𝐸𝑆	 → 𝐸𝑆∗ → 𝐸 + 𝑃	 (4.1) 
 
𝐸 is the enzyme (β-lactamase), 𝑆 is the substrate (β-lactam), 𝐸𝑆 is the enzyme-substrate 
complex, 𝐸𝑆∗ is the acyl-intermediate, and 𝑃 is the product (hydrolyzed β-lactam). k1 and k-1 are 
the binding and unbinding rates, respectively. k2 is the acylation rate and k3 is the deacylation 






The Ω-loop (and particularly E166) is necessary for the deacylation (𝑘&) of β-lactams, and 
deacylation is the rate-limiting step for benzylpenicillin hydrolysis [15]. However, the acylation 
rate (𝑘%) is the rate-limiting step for cefotaxime hydrolysis [16] and has been proposed to be the 
distinguishing feature between the hydrolysis of penicillins and cephalosporins [15]. Thus, I 
hypothesize that the open Ω-loop pocket population is correlated with the acylation rate. 
 
Single turn-over and steady-state kinetics can be used to monitor the hydrolysis of slow 
substrates by β-lactamases in order to determine the individual acylation and deacylation rates 
[14, 16]. However, determining the rates for β-lactamases hydrolyzing good substrates like 





is too much overlap between the benzylpenicillin and enzyme absorption) nor the stopped flow 
(the reaction is too fast) are possible [15]. The acylation and deacylation rates instead can be 
determined using a quenched flow equipped with three syringes to quantify the fraction of acyl-
enzyme (𝐸𝑆∗) [15]. To date, all of the rate constants have been determined for β-lactamase I, 
PC1, and RTEM hydrolyzing benzylpenicillin as well as for β-lactamase I and PC1 hydrolyzing 
other substrates [17]. 
 
I propose performing DTNB labeling on TEM E104K and TEM E104K/G238S, as these variants 
were shown computationally to have different populations of open Ω-loop pocket conformations 
[5]. These variants close the Ω-loop pocket and have catalytic rates against benzylpenicillin that 
are correlated with their open Ω-loop pocket conformations. Combined with the data for wild-
type TEM, DTNB labeling experiments will corroborate the computational data as well as 
provide a quantitative measure of the pocket open population. Alternatively, the Ω-loop pocket 
populations could be used for wild-type TEM, TEM E240D, and TEM E240D/R241P. TEM 
R241P will likely not be useful for this study as it removes the Ω-loop pocket entirely and has a 
higher catalytic rate against benzylpenicillin as compared to TEM E240D/R241P. 
 
Next, I propose determining the acylation and deacylation rates of the variants of interest for 
benzylpenicillin using the quenched flow measurement of the acyl-enzyme and for cefotaxime 
using the stopped flow, single turn-over kinetics methodology. I expect a negative correlation 
between the acylation rate (against both benzylpenicillin and cefotaxime) and the population of 
open Ω-loop pocket, meaning that closing the Ω-loop pocket increases the acylation rate. This 
increased acylation rate would be especially beneficial for cefotaxime hydrolysis, as the wild-
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type enzyme has a slow acylation rate. For benzylpenicillin hydrolysis, an increased acylation 
rate likely comes at the cost of a decreased ability to bind and release product and thus a 
corresponding decrease in overall catalytic efficiency. If needed, the binding and unbinding rates 
can be determined by measuring the catalytic efficiencies as a function of viscosity [17]. 
 
We showed in Chapter 2 that an open cryptic pocket population is correlated with protein 
function, as measured by catalytic efficiency. Specifically, the changes seen in catalytic 
efficiency are due to changes in catalytic rate. Using NMR and molecular dynamics simulation 
data, we also proposed a model for how the open and closed pocket conformations might affect 
the hydrolysis reaction, which the experiments proposed above would more explicitly test. These 
experiments would also add to our understanding of how cryptic pocket opening in enzymes is 
connected to enzyme activity. The general principles learned in these studies, particularly when 
combined with the work proposed in the previous section, would aid in protein design.  
 
 
4.3.3 Determine the Cooperativity of the Ω-loop Pocket and the Helix 11/12 
Pocket in TEM β-lactamase 
We found that the dynamics of the Ω-loop pocket in TEM were able to affect the active site 
residues and ultimately activity against different classes of substrates. Besides the Ω-loop pocket, 
there is another known cryptic pocket in TEM β-lactamase between helices 11 and 12, and we 
call this the helix 11/12 pocket (Figure 4.2). As this pocket was found serendipitously during a 
drug screening campaign, it is known that this cryptic pocket has the ability to allosterically 
affect the active site [18]. In fact, several allosteric modulators have been discovered by targeting 
this pocket [19]. Both cryptic pockets individually have allostery with the active site, but do they 
allosterically communicate with one another? 
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Figure 4.2. TEM β-lactamase has an additional cryptic pocket termed the helix 11/12 pocket. The structure 
shown is the crystal structure (PDB: 1pzo) where an inhibitor was found to bind into a pocket absent in the ligand-
free crystal structure. The inhibitor structure has been removed from the pocket here in order to highlight the pocket 
opening. The regions of the Ω-loop pocket and helix 11/12 pocket are highlighted with dashed circles. 
 
The residues that were found via NMR CEST experiments to participate in the exchange 
between the ground state and open cryptic pocket excited state were those in the region of the Ω-
loop pocket as well as some residues within the β-sheet between the Ω-loop and helix 11/12 
pockets. We also saw a similar behavior from the CARDS analysis on TEM where the Ω-loop 
community continues into the β-sheet. These results suggest that the two pockets communicate 
with one another, perhaps through the β-sheet. Communication of distal sites via a β-sheet is an 
emerging strategy of allosteric communication [20]. As each open cryptic pocket structure has 
been observed computationally [21-23], but there is currently no structure of both pockets open 
at the same time, I hypothesize that the two pockets are negatively coupled in that opening one 
pocket closes the other. 
 
To test this hypothesis, I propose using the L286C mutation in TEM to monitor opening of the 
helix 11/12 pocket and then comparing the labeling of the helix 11/12 pocket in both wild-type 
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and R241P. I expect that the R241P mutation, which closes the Ω-loop pocket, will increase the 
population of open helix 11/12 pocket as compared to wild type. Previously, the pocket opening 
rate of the helix 11/12 pocket was determined as the labeling was in the EX1 regime [22]. 
However, lower DTNB concentrations could push the labeling to the EXX regime, making the 
determination of the pocket population possible. 
 
Less is known about the helix 11/12 pocket in terms of its conservation across β-lactamases, 
connection to activity, and mutations which enhance/suppress pocket opening. Preliminary data 
suggest that unlike the Ω-loop pocket, the helix 11/12 pocket is not conserved in CTX-M-9 
(Figure A.3). It would be interesting to know if GNCA contains a helix 11/12 pocket, as this 
would suggest that the Ω-loop pocket was gained in an ancestor of TEM and CTX-M-9 but then 
the helix 11/12 pocket was lost in an ancestor of CTX-M-9. This could be tested by 
incorporating a cysteine residue at position 286 in GNCA and monitoring labeling. Alternatively, 
the helix 11/12 pocket might only exist in TEM β-lactamase, making the reason for its allosteric 
connection to activity unclear. Additionally, the helix 11/12 pocket could be used to gain 
understanding of the sequence determinants of cryptic pocket opening, using a similar strategy to 
the one outlined in a previous section. Then, mutations identified to close the helix 11/12 pocket 
in TEM could be used to test the effects of closing this pocket on the open population of the Ω-
loop pocket. Again, I would expect that closing the helix 11/12 pocket would open the Ω-loop 




Understanding the connectivity of multiple cryptic pockets adds to our understanding of allostery 
in proteins, and the existence of multiple connected pockets increases the therapeutic potential of 
a protein. Finding specific and tight binders even to known and well-defined pockets can be 
difficult but having multiple pockets in a protein that are able to affect the active site would 
increase the potential of success. Particularly, if drug binding to a pocket undesirably perturbs an 
important residue, modulating the dynamics of that pocket via drug binding to an allosterically 
connected pocket presents a new therapeutic opportunity. 
 
 
4.4 Considering Excited States Along the Protein Folding 
Pathway Increases our Ability to Predict Fitness from 
Protein Properties  
While the catalytic efficiency of an enzyme typically well-describes its function, in Chapter 3, I 
found that the catalytic efficiency of TEM β-lactamase variants alone only explained about 70% 
of the variance in bacterial fitness, as measured by minimal inhibitory concentration (MIC). 
Strikingly, two variants with similar activities fell far off of the 1:1 correlation line in opposite 
directions. This suggests that one or more protein properties also significantly contribute to 
fitness. 
 
It has previously been suggested that because TEM variants are very stable, particularly with 
fraction folded values above 99%, stability values add no predictive power [24]. However, the 
authors of this study assumed a two-state model to describe TEM folding/unfolding. A two-state 
folding model determines the free energy difference between the ground state and the unfolded 
state and is often used because of the cooperative nature of protein folding. If a folding 
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intermediate is not significantly populated or does not produce a signal different from the ground 
or unfolded states, than it cannot be seen in bulk, in vitro measurements of stability. In order to 
evaluate the validity of the two-state assumption, protein stability is measured using multiple, 
independent signals. If the transitions for each normalized curve do not overlay, this suggests 
that there are more than two states. That being said, I found that three states (the ground state, the 
intermediate state, and the unfolded state) can be observed from a single stability experiment 
monitored using circular dichroism (CD) at 222 nm.  
 
While the intermediate state is a protein excited state with a lower energy (higher probability) 
than the unfolded state, I found that the free energy differences between the ground and 
intermediate states still correspond to fraction folded values above 99%. However, I 
hypothesized that destabilization that leads to partial unfolding would make the protein 
susceptible to aggregation and/or degradation in the cellular environment. By measuring stability 
using a pulse proteolysis assay, I found that the TEM folding intermediate is in fact susceptible 
to proteolytic digestion. By measuring protein cellular abundance, I also found that destabilized 
variants (i.e., those with larger concentrations of the folding intermediate) have drastically 
reduced concentrations in the cell. These results taken together provide evidence for the 
importance of stability in determining fitness and suggest that in vitro measurements of stability 
may add predictive power, though not expressed as fraction folded. 
 
Next, I derived an expression to describe how stability would alter the concentration of the 
ground state conformation by first considering a kinetic scheme in which the protein could be 
synthesized to the intermediate state (I assumed the concentration of the unfolded state to be 
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negligible) and then fold to the ground state. I also considered that the protein could unfold back 
to the intermediate state and be proteolyzed from there. Using catalytic efficiency values, 
stability values, and the resulting model, I was then able to predict 99% of the variance in MIC. 
In order to achieve this correlation, I applied a stability threshold based on the observation that 
stability past a certain point does not increase cellular abundance or fitness. My results are in 
excellent agreement with previous work [25] that suggested that stability accounts for about 29% 
of the variance in MIC and that TEM is only about -1.7 kcal/mol stable in vivo. 
 
In summary, I found that both protein activity and stability contribute to bacterial fitness. 
Sufficient catalytic efficiency is needed to order to degrade β-lactam antibiotics before they 
reach their targets, but increases in catalytic efficiency often come at the cost of stability. 
Because the cellular environment contains protein quality control machinery, like proteases, 
decreases in stability can lead to decreases in protein cellular abundance. This is particularly true 
because a protein samples excited state conformations, and a protein does not need to unfold 
entirely in order to aggregate or be degraded. So, while it can still be beneficial to have a 
decreased number of highly active enzymes (as I saw with TEM E104K/G238S), stability is an 
important consideration for the quantitative prediction of fitness.  
 
4.5 Limitations of my Model for Predicting Fitness. 
As with any model, my model is not appropriate to use in all situations. To start, I used a 
measure of fitness, minimal inhibitory concentration of an antibiotic, that only gives a measure 
of the protein’s fitness in the presence of antibiotic. In the absence of antibiotic, the activity of 
TEM becomes nonessential, though the stability of the protein remains important. The bacteria 
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may even have a lower tolerance for destabilized variants that provide no useful function. In 
deriving my model, I also assume that the synthesis and proteolysis rates are independent of the 
TEM variant being produced. As the variants differ by only a couple of nucleotides, the synthesis 
rate is unlikely to be drastically affected, though this was not explicitly tested. The proteolysis 
rates could more likely change due to a single amino acid change if the resulting mutation 
introduces a cut site for the native protease. Furthermore, the synthesis and proteolysis rates 
become increasingly important with an increase in sequence diversity. Finally, it is possible that 
addition of stability in my model fits to the data very well trivially due to the addition of 
parameters. The validation of the model on a new set of variants not used to fit the model 
provides evidence that this is not the case, but it is difficult to determine if a model is overfit 
without additional data.   
 
 
4.6 Future Studies to Validate my Model for Predicting 
Fitness 
4.5.1 Test the Generalizability of the Model by Using Different Classes of 
Antibiotics 
I found that my model explained 99% of the variance in the MIC of the third-generation 
cephalosporin, cefotaxime. I expect that my model is generalizable to other antibiotics as the 
protein factors which contribute to fitness are unlikely to change with the class of antibiotic, but 
this has yet to be tested.  Activity is dependent on the antibiotic tested, but I do not expect 
stability to be. For substrates which are slowly hydrolyzed, there may be an appreciable amount 
of time in which the bound substrate stabilizes the enzyme. However, I did not find this to be the 
case for the slowly hydrolyzed substrate cefotaxime. 
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Figure 4.3 Structures of cefotaxime, benzylpenicillin, and imipenem. Cefotaxime is the third-generation 
cephalosporin that was used to develop the model in Chapter 3. Benzylpenicillin is a penicillin and the classic 
substrate of β-lactamases. Imipenem is a carbapenem. 
 
Thus, I hypothesize that measuring the TEM variants’ activity against benzylpenicillin (a 
penicillin) and imipenem (a carbapenem), combined with known stability data, will be predictive 
of MIC of the respective antibiotics (Figure 4.3). The 𝑍′ parameter will need to change as the 
permeability of the antibiotic through the outer membrane is included in this parameter and is an 
antibiotic-specific value. However, because this is a known quantity, the originally fit 𝑍′ 
parameter can simply be scaled accordingly.  
 
These experiments would be beneficial as the more generalizable the model is, the more useful it 
can be. Application to different classes of antibiotics also suggests a good understanding of the 
protein properties which contribute to fitness and that only two parameters are needed to describe 
factors independent of the protein variant being produced. 
 
 
4.5.2 Determine Which Protease(s) Degrade TEM β-lactamase in vivo 
I found that destabilized TEM variants had drastically reduced cellular protein abundance due to 
proteolytic digestion from a TEM excited state. I tested the proteolytic susceptibility of the 
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folding intermediate population using the protease thermolysin and fit a parameter which 
contained an intrinsic proteolysis rate. However, thermolysin is an extracellular 
metalloendopeptidase secreted by the Gram-positive, thermophilic bacterium 
Bacillus thermoproteolyticus [26] and is thus unlikely to be the protease that degrades TEM 
intracellularly in Gram-negative Escherichia coli. This leads to the question: which protease is 
responsible for degrading TEM β-lactamase in E.coli? 
 
There are 10 known periplasmic proteases: degP, degQ, ompT, ptrA, tsp, ycaL, ydgD, loiP, bepA, 
and yhiJ [27]. Of these, five proteases (ompT, ptrA, tsp, loiP, and bepA) are unlikely to degrade 
TEM based on their known substrates, and three proteases are uncharacterized (ycaL, ydgD, and 
yhiJ). The most likely proteases that degrade TEM are DegP, which degrades misfolded proteins 
[28] and DegQ which degrades partially unfolded substrates [29]. Thus, I hypothesize that TEM 
is degraded in the periplasm by DegP and/or DegQ. 
 
To determine if these proteases do in fact degrade TEM in vivo, I propose performing the same 
cellular protein abundance assays from Chapter 3 but with cells lacking each protease. I expect 
that when the native protease is absent, there will be increased cellular abundance of the 
destabilized TEM variants, particularly in the whole cell lysate and insoluble fractions. If neither 
of these proteases alter TEM abundance, either alone or in combination, the three 
uncharacterized periplasmic proteases could be tested next. 
 
Determining the native protease which degrades TEM would allow for the measurement of the 
intrinsic proteolytic rate of that enzyme, a value currently fit within the 𝑍′ parameter in my 
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model. The more information we have about the biological context of TEM and specifically the 
more quantitative information we have about the factors independent of the TEM variant being 
produced, the better we can predict bacterial fitness from the biophysical properties of TEM 
alone. Additionally, knowing the native protease would allow us to determine if the folding 
intermediate seen during in vitro measurements of stability is the state which gets degraded by 
this protease (as it is for thermolysin). This would provide further insight into the protein energy 
landscape of TEM β-lactamase and provide further evidence for the functional importance of 
excited state conformations. 
 
 
4.7 Closing Thoughts 
It is well-established that proteins are dynamic molecules, but studying the multiple 
conformations a protein adopts and relating their structures and probabilities to the protein’s 
function remains a challenge. However, proteins are nanomolecular machines and, like any 
machine, if they do not move, they cannot function. Thus, the questions surrounding protein 
dynamics are difficult but extremely important. In recent years there have been significant 
advances towards understanding how proteins move and an increased appreciation for those 
movements. This thesis specifically emphasizes the utility of considering the excited states of 
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Figure A.1. One cysteine labels in both wild-type (WT) MTB and MTB A285C. The normalized DTNB labeling 
traces for WT MTB (orange circles) and MTB A285C (light orange pentagons) plateau at one cysteine labeling. We 
know from Chapter 2 that the cysteine which labels in WT MTB is C287. We introduced the A285C mutation in 
order to test for the presence of the helix 11/12 pocket in MTB. While only one cysteine labels in both variants, it is 
unclear if the difference in labeling rate is due to the A285C mutation increasing the solvent exposure of C287 or if 




Figure A.2. DTNB labeling WT MTB inhibits activity against nitrocefin. Michaelis-Menten kinetics were 
measured for unlabeled wild-type MTB (orange solid line) and TNB-labeled wild-type MTB (dark orange dashed 
line). Error bars represent the standard deviation of three independent runs. We know from Chapter 2 that the 
cysteine which labels in wild-type MTB is C287. This data suggests allosteric communication between the region of 
position 287 and the active site. Interestingly, the differences in catalytic efficiency are due to changes in both the 




Figure A.3. Both cysteines label in CTX-M A283C. (Left) The normalized DTNB labeling trace for wild-type 
(WT) CTX-M (cyan circles), as expected, plateaus at one cysteine labeling. However, the labeling trace for CTX-M 
A283C (light cyan diamonds) plateaus at a value greater than one cysteine labeling and is well-fit by a double 
exponential. I introduced the A283C mutation in order to test for the presence of the helix 11/12 pocket in CTX-M. 
(Right) I continued the analysis by measuring the observed labeling rate as a function of DTNB concentration and 
find that the slower cysteine (pentagons) labels on the order of magnitude of what is expected for protein unfolding. 
Error bars represent the standard deviation of three independent runs. I conclude that only one cysteine labeling 
corresponds to pocket opening in CTX-M A283C. However, it is still unclear if the faster labeling cysteine 
(diamonds) is at position 69 or 283. Either way, this data provides evidence for the allosteric communication 




Figure A.4. The G240E mutation does not open the Ω-loop pocket in GNCA. The normalized labeling trace for 




Figure A.5. DTNB labeling of wild-type CTX-M results in a faster proteolysis rate while the presence of the 
compound NCI147639 results in a slower proteolysis rate. I measured the proteolysis rate (by thermolysin) of 
wild-type CTX-M unlabeled (cyan solid line), TNB-labeled (dark cyan dashed line), and in the presence of the 
compound NCI147639 (dark gray dash dotted line). TNB-labeling CTX-M is known to inhibit activity, presumably 
due to sterically blocking the Ω-loop [1]. Labeling also increases the proteolysis rate by over an order of magnitude. 
Compound binding, on the other hand, is known to stabilize proteins [2]. Addition of the NCI147639 compound 




Figure A.6. TEM β-lactamase folding is not reversible by thermal denaturation. Fluorescence signal as a 
function of temperature was measured by first increasing temperature (lime green) to measure unfolding and then 
decreasing temperature (dark green) to measure refolding. The loss of signal in the refolding trace indicates that 
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